WO2024119440A1 - Biodegradable multi-block copolymers comprising linking units derived from cyclic ketene acetal - Google Patents
Biodegradable multi-block copolymers comprising linking units derived from cyclic ketene acetal Download PDFInfo
- Publication number
- WO2024119440A1 WO2024119440A1 PCT/CN2022/137597 CN2022137597W WO2024119440A1 WO 2024119440 A1 WO2024119440 A1 WO 2024119440A1 CN 2022137597 W CN2022137597 W CN 2022137597W WO 2024119440 A1 WO2024119440 A1 WO 2024119440A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copolymer
- linking units
- ester linking
- ethylenically unsaturated
- carbonyl
- Prior art date
Links
- -1 cyclic ketene acetal Chemical class 0.000 title claims abstract description 154
- 229920001400 block copolymer Polymers 0.000 title description 8
- 229920001577 copolymer Polymers 0.000 claims abstract description 177
- 239000000203 mixture Substances 0.000 claims abstract description 150
- 150000002148 esters Chemical class 0.000 claims abstract description 118
- 239000004744 fabric Substances 0.000 claims abstract description 42
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims abstract description 38
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 31
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 30
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 30
- 239000001301 oxygen Substances 0.000 claims abstract description 30
- 239000003599 detergent Substances 0.000 claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 claims description 50
- 229920000728 polyester Polymers 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 36
- 238000005809 transesterification reaction Methods 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- JIFCOORMJVPBTN-UHFFFAOYSA-N 2-methylidene-1,3,6-trioxocane Chemical compound C=C1OCCOCCO1 JIFCOORMJVPBTN-UHFFFAOYSA-N 0.000 claims description 28
- 229940088598 enzyme Drugs 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 19
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 14
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 13
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 claims description 12
- 229960005323 phenoxyethanol Drugs 0.000 claims description 12
- AVUFZLGLMCACRE-UHFFFAOYSA-N 2-methylidene-1,3-dioxepane Chemical compound C=C1OCCCCO1 AVUFZLGLMCACRE-UHFFFAOYSA-N 0.000 claims description 10
- 108091005804 Peptidases Proteins 0.000 claims description 10
- 239000004365 Protease Substances 0.000 claims description 10
- 239000004599 antimicrobial Substances 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- 108010065511 Amylases Proteins 0.000 claims description 7
- 102000013142 Amylases Human genes 0.000 claims description 7
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 7
- 239000005977 Ethylene Substances 0.000 claims description 7
- 235000019418 amylase Nutrition 0.000 claims description 7
- 102000004316 Oxidoreductases Human genes 0.000 claims description 6
- 108090000854 Oxidoreductases Proteins 0.000 claims description 6
- 102000035195 Peptidases Human genes 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- 108010005400 cutinase Proteins 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 5
- 108010084185 Cellulases Proteins 0.000 claims description 4
- 102000005575 Cellulases Human genes 0.000 claims description 4
- 108090001060 Lipase Proteins 0.000 claims description 4
- 239000004367 Lipase Substances 0.000 claims description 4
- 102000004882 Lipase Human genes 0.000 claims description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- 238000004900 laundering Methods 0.000 claims description 4
- 235000019421 lipase Nutrition 0.000 claims description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 4
- 239000011976 maleic acid Substances 0.000 claims description 4
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 3
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 claims description 3
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 108010059820 Polygalacturonase Proteins 0.000 claims description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 3
- 229940025131 amylases Drugs 0.000 claims description 3
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 229920001567 vinyl ester resin Polymers 0.000 claims description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 3
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 2
- VHMYBWIOLGKSHO-UHFFFAOYSA-N 2-methylidene-1,3-dioxolane Chemical compound C=C1OCCO1 VHMYBWIOLGKSHO-UHFFFAOYSA-N 0.000 claims description 2
- DMKKMGYBLFUGTO-UHFFFAOYSA-N 2-methyloxirane;oxirane Chemical compound C1CO1.C1CO1.CC1CO1 DMKKMGYBLFUGTO-UHFFFAOYSA-N 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 108010002430 hemicellulase Proteins 0.000 claims description 2
- GAGSAAHZRBTRGD-UHFFFAOYSA-N oxirane;oxolane Chemical compound C1CO1.C1CCOC1 GAGSAAHZRBTRGD-UHFFFAOYSA-N 0.000 claims description 2
- HNPFNYDBAOYNSY-UHFFFAOYSA-N oxirane;oxolane Chemical compound C1CO1.C1CO1.C1CCOC1 HNPFNYDBAOYNSY-UHFFFAOYSA-N 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 51
- 229920000642 polymer Polymers 0.000 description 32
- 150000003254 radicals Chemical group 0.000 description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 238000009472 formulation Methods 0.000 description 17
- 239000007788 liquid Substances 0.000 description 17
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 16
- 239000000654 additive Substances 0.000 description 15
- 150000001412 amines Chemical class 0.000 description 15
- 229920001223 polyethylene glycol Polymers 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 238000006116 polymerization reaction Methods 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 13
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 11
- 229920002873 Polyethylenimine Polymers 0.000 description 10
- 229910052783 alkali metal Inorganic materials 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 229920000578 graft copolymer Polymers 0.000 description 9
- 239000007844 bleaching agent Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 159000000000 sodium salts Chemical class 0.000 description 7
- 230000000087 stabilizing effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 230000000181 anti-adherent effect Effects 0.000 description 6
- 150000004985 diamines Chemical class 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000011572 manganese Substances 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 230000000171 quenching effect Effects 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 239000003139 biocide Substances 0.000 description 5
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 5
- 239000002270 dispersing agent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 150000002191 fatty alcohols Chemical class 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 5
- CHJMFFKHPHCQIJ-UHFFFAOYSA-L zinc;octanoate Chemical compound [Zn+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O CHJMFFKHPHCQIJ-UHFFFAOYSA-L 0.000 description 5
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 150000001860 citric acid derivatives Chemical class 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 238000003380 quartz crystal microbalance Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 239000003760 tallow Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 3
- FNORIJBDBYRSNG-UHFFFAOYSA-N BrCC1OCCOCCO1 Chemical compound BrCC1OCCOCCO1 FNORIJBDBYRSNG-UHFFFAOYSA-N 0.000 description 3
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 150000001408 amides Chemical group 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 125000000732 arylene group Chemical group 0.000 description 3
- 238000006065 biodegradation reaction Methods 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 125000005620 boronic acid group Chemical class 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 229960000587 glutaral Drugs 0.000 description 3
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 229920005646 polycarboxylate Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 238000010526 radical polymerization reaction Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WYKYCHHWIJXDAO-UHFFFAOYSA-N tert-butyl 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOC(C)(C)C WYKYCHHWIJXDAO-UHFFFAOYSA-N 0.000 description 3
- 238000009827 uniform distribution Methods 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 description 2
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- UDQMXYJSNNCRAS-UHFFFAOYSA-N 2,3-dichlorophenylpiperazine Chemical compound ClC1=CC=CC(N2CCNCC2)=C1Cl UDQMXYJSNNCRAS-UHFFFAOYSA-N 0.000 description 2
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 2
- RUZAHKTXOIYZNE-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid;iron(2+) Chemical compound [Fe+2].OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O RUZAHKTXOIYZNE-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010012186 Delayed delivery Diseases 0.000 description 2
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- KYIKRXIYLAGAKQ-UHFFFAOYSA-N abcn Chemical compound C1CCCCC1(C#N)N=NC1(C#N)CCCCC1 KYIKRXIYLAGAKQ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- GHDBLWVVUWTQCG-UHFFFAOYSA-N acetonitrile;n,n-dimethylmethanamine Chemical class CC#N.CN(C)C GHDBLWVVUWTQCG-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- GGNQRNBDZQJCCN-UHFFFAOYSA-N benzene-1,2,4-triol Chemical compound OC1=CC=C(O)C(O)=C1 GGNQRNBDZQJCCN-UHFFFAOYSA-N 0.000 description 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- BYNQFCJOHGOKSS-UHFFFAOYSA-N diclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1 BYNQFCJOHGOKSS-UHFFFAOYSA-N 0.000 description 2
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000000914 diffusion-ordered spectroscopy Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- 150000002466 imines Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000010409 ironing Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920005684 linear copolymer Polymers 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XOMRRQXKHMYMOC-NRFANRHFSA-N (3s)-3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C XOMRRQXKHMYMOC-NRFANRHFSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- ZGZHWIAQICBGKN-UHFFFAOYSA-N 1-nonanoylpyrrolidine-2,5-dione Chemical compound CCCCCCCCC(=O)N1C(=O)CCC1=O ZGZHWIAQICBGKN-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- TWDUKWCXYKWSKZ-UHFFFAOYSA-N 2-(7-methyloctanoyloxy)benzenesulfonic acid Chemical class CC(C)CCCCCC(=O)OC1=CC=CC=C1S(O)(=O)=O TWDUKWCXYKWSKZ-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- DMICZDHECYMGHD-KTKRTIGZSA-N 2-[bis(2-hydroxyethyl)-[(Z)-octadec-9-enyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](CCO)(CCO)CC([O-])=O DMICZDHECYMGHD-KTKRTIGZSA-N 0.000 description 1
- QEJSCTLHIOVBLH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)-octadecylazaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](CCO)(CCO)CC([O-])=O QEJSCTLHIOVBLH-UHFFFAOYSA-N 0.000 description 1
- XPTYFQIWAFDDML-UHFFFAOYSA-N 2-aminoacetic acid;ethanol Chemical class CCO.NCC(O)=O.NCC(O)=O XPTYFQIWAFDDML-UHFFFAOYSA-N 0.000 description 1
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical class OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 description 1
- LUYIHWDYPAZCNN-UHFFFAOYSA-N 2-butyl-1,2-benzothiazol-3-one Chemical compound C1=CC=C2C(=O)N(CCCC)SC2=C1 LUYIHWDYPAZCNN-UHFFFAOYSA-N 0.000 description 1
- WGPVWXXJNUNBNB-UHFFFAOYSA-N 2-carboxyphenolate;2-hydroxyethylazanium Chemical compound NCCO.OC(=O)C1=CC=CC=C1O WGPVWXXJNUNBNB-UHFFFAOYSA-N 0.000 description 1
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 description 1
- KDTZBYPBMTXCSO-UHFFFAOYSA-N 2-phenoxyphenol Chemical compound OC1=CC=CC=C1OC1=CC=CC=C1 KDTZBYPBMTXCSO-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- JSIAIROWMJGMQZ-UHFFFAOYSA-N 2h-triazol-4-amine Chemical class NC1=CNN=N1 JSIAIROWMJGMQZ-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- ONYHQNURMVNRJZ-QXMHVHEDSA-N 3-[3-[[(Z)-docos-13-enoyl]amino]propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O ONYHQNURMVNRJZ-QXMHVHEDSA-N 0.000 description 1
- CNIGBCBFYDWQHS-QXMHVHEDSA-N 3-[dimethyl-[3-[[(z)-octadec-9-enoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O CNIGBCBFYDWQHS-QXMHVHEDSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical group C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical group [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229940123150 Chelating agent Drugs 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N E-Sorbic acid Chemical compound C\C=C\C=C\C(O)=O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical group CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000605014 Homo sapiens Putative L-type amino acid transporter 1-like protein MLAS Proteins 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 102100038206 Putative L-type amino acid transporter 1-like protein MLAS Human genes 0.000 description 1
- 238000000961 QCM-D Methods 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical class C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ZUBJEHHGZYTRPH-KTKRTIGZSA-N [(z)-octadec-9-enyl] hydrogen sulfate Chemical compound CCCCCCCC\C=C/CCCCCCCCOS(O)(=O)=O ZUBJEHHGZYTRPH-KTKRTIGZSA-N 0.000 description 1
- XMUZQOKACOLCSS-UHFFFAOYSA-N [2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=CC=C1CO XMUZQOKACOLCSS-UHFFFAOYSA-N 0.000 description 1
- JNGWKQJZIUZUPR-UHFFFAOYSA-N [3-(dodecanoylamino)propyl](hydroxy)dimethylammonium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-] JNGWKQJZIUZUPR-UHFFFAOYSA-N 0.000 description 1
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 description 1
- RUSUZAGBORAKPY-UHFFFAOYSA-N acetic acid;n'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCNCCN RUSUZAGBORAKPY-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 1
- WFACTXCBWPYESL-UHFFFAOYSA-N acetonitrile;4-methylmorpholine Chemical class CC#N.CN1CCOCC1 WFACTXCBWPYESL-UHFFFAOYSA-N 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229940090948 ammonium benzoate Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960002233 benzalkonium bromide Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- KHSLHYAUZSPBIU-UHFFFAOYSA-M benzododecinium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 KHSLHYAUZSPBIU-UHFFFAOYSA-M 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 125000003354 benzotriazolyl group Chemical class N1N=NC2=C1C=CC=C2* 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000004301 calcium benzoate Chemical class 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical class O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- BLCKNMAZFRMCJJ-UHFFFAOYSA-N cyclohexyl cyclohexyloxycarbonyloxy carbonate Chemical compound C1CCCCC1OC(=O)OOC(=O)OC1CCCCC1 BLCKNMAZFRMCJJ-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- BKRJTJJQPXVRRY-UHFFFAOYSA-M dodecyl-(2-hydroxyethyl)-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCO BKRJTJJQPXVRRY-UHFFFAOYSA-M 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- YCUBDDIKWLELPD-UHFFFAOYSA-N ethenyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC=C YCUBDDIKWLELPD-UHFFFAOYSA-N 0.000 description 1
- IGBZOHMCHDADGY-UHFFFAOYSA-N ethenyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC=C IGBZOHMCHDADGY-UHFFFAOYSA-N 0.000 description 1
- WNMORWGTPVWAIB-UHFFFAOYSA-N ethenyl 2-methylpropanoate Chemical compound CC(C)C(=O)OC=C WNMORWGTPVWAIB-UHFFFAOYSA-N 0.000 description 1
- RASNHPFIOGUOOT-UHFFFAOYSA-N ethenyl 6-methylheptanoate Chemical compound CC(C)CCCCC(=O)OC=C RASNHPFIOGUOOT-UHFFFAOYSA-N 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- CMDXMIHZUJPRHG-UHFFFAOYSA-N ethenyl decanoate Chemical compound CCCCCCCCCC(=O)OC=C CMDXMIHZUJPRHG-UHFFFAOYSA-N 0.000 description 1
- GFJVXXWOPWLRNU-UHFFFAOYSA-N ethenyl formate Chemical compound C=COC=O GFJVXXWOPWLRNU-UHFFFAOYSA-N 0.000 description 1
- BLZSRIYYOIZLJL-UHFFFAOYSA-N ethenyl pentanoate Chemical compound CCCCC(=O)OC=C BLZSRIYYOIZLJL-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000002979 fabric softener Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- PMYUVOOOQDGQNW-UHFFFAOYSA-N hexasodium;trioxido(trioxidosilyloxy)silane Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] PMYUVOOOQDGQNW-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- 150000002560 ketene acetals Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000010412 laundry washing Methods 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 108010062085 ligninase Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- PJJZFXPJNUVBMR-UHFFFAOYSA-L magnesium benzoate Chemical class [Mg+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 PJJZFXPJNUVBMR-UHFFFAOYSA-L 0.000 description 1
- 229940072082 magnesium salicylate Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 229920006030 multiblock copolymer Polymers 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- NYNKJVPRTLBJNQ-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-dodecylpropane-1,3-diamine Chemical compound CCCCCCCCCCCCN(CCCN)CCCN NYNKJVPRTLBJNQ-UHFFFAOYSA-N 0.000 description 1
- ZUHZZVMEUAUWHY-UHFFFAOYSA-N n,n-dimethylpropan-1-amine Chemical compound CCCN(C)C ZUHZZVMEUAUWHY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical class OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- SJGALSBBFTYSBA-UHFFFAOYSA-N oxaziridine Chemical compound C1NO1 SJGALSBBFTYSBA-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007248 oxidative elimination reaction Methods 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-K pentetate(3-) Chemical compound OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QPCDCPDFJACHGM-UHFFFAOYSA-K 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229910052615 phyllosilicate Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical class [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 1
- 229960003629 potassium salicylate Drugs 0.000 description 1
- CHHHXKFHOYLYRE-STWYSWDKSA-M potassium sorbate Chemical compound [K+].C\C=C\C=C\C([O-])=O CHHHXKFHOYLYRE-STWYSWDKSA-M 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 238000002494 quartz crystal microgravimetry Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical compound CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Abstract
The present invention relates to a copolymer, which comprises (i) ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and optionally interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl "-C (O) -" and the oxygen "-O-" of the moiety of -C (O) -O-, and (ii) blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-, provided that the ester linking units containing a moiety of -C (O) -O-are interrupted by the polyoxyalkylene-carbonyl segment between the carbonyl "-C (O) -" and the oxygen "-O-" of the moiety of -C (O) -O-when the blocks are derived from one ethylenically unsaturated comonomer. The present invention also relates to a process for preparing the copolymer, and use thereof in detergent compositions and fabric and home care compositions.
Description
The invention relates to biodegradable multi-block copolymers containing linking units derived from cyclic ketene acetal between the blocks, a process for preparing the biodegradable multi-block copolymers containing linking units derived from cyclic ketene acetal between the blocks, and use thereof in detergent compositions and fabric and home care compositions.
It is known that polymers whose carbon backbone is interrupted by functional groups such as ester, amide, carbonate, urethane or ether groups and whose hydrocarbon moieties between the functional groups are predominantly of an aliphatic nature are degradable by microorganisms. In contrast, polyolefins with a purely carbon backbone are resistant to a microbial attack. An exception is, for example, polyvinyl alcohol, which is completely degraded to carbon dioxide and water after oxidative cleavage. In contrast polyvinyl acetate is only degraded with difficulty, since it initially has to largely hydrolyze to polyvinyl alcohol.
DE 3930097A1 discloses UV-crosslinkable copolymers composed of cyclic olefinically unsaturated ring-opening polymerizable monomers, olefinically unsaturated monomers and olefinically unsaturated acetophenone or benzophenone derivatives. These polymers are suitable as coatings, for impregnating materials, or as adhesives and, in particular, as pressure-sensitive adhesive.
US 5,912,312A discloses a copolymer containing vinyl pyrrolidone and 2-methylene-1, 3-dioxepane which is hydrolytically degradable in aqueous acid or basic solutions and biodegradable. It is described in the patent application that the copolymer is particularly advantageous as binders in such products as fish feed, and also useful as a dispersant in systems where PVP itself has been the conventional polymer of choice.
In recent time, there is an increasing demand to provide polymers with higher biodegradability, for example in fields of detergent and fabric treatment product. Polymeric additives are widely used in detergents and fabric treatment formulations, for example dispersants, anti-graying agents, dye transfer inhibitors, dye fixation agents, and the like. It is still challenging to develop such polymer additives, since the polymers as the additives are required to have not only high biodegradability, but also desirable functional application properties.
Summary of Invention
It is an object of the present invention to provide a polymer useful in detergent compositions and fabric and home care compositions which has a higher biodegradability and desirable functional properties.
It was found by the inventors that the object can be achieved by a copolymer comprising ester linking units derived from a cyclic ketene acetal and blocks derived from one or more ethylenically unsaturated comonomers, wherein the blocks are linked by the ester linking units derived from a cyclic ketene acetal.
Accordingly, in the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and optionally interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-,
- blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-,
provided that the ester linking units containing a moiety of -C (O) -O-are interrupted by the polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-when the blocks are derived from one ethylenically unsaturated comonomer.
In some embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and
- blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
In some other embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O, and
- blocks derived from two or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
Preferably, the copolymer in the first aspect has a uniform distribution of ester linking units between the blocks derived from one or more ethylenically unsaturated comonomers in polymeric backbones.
In the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes steps of
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester, or (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units,
wherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
In some embodiments according to the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester.
In some other embodiments according to the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units,
wherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
In the third aspect, the present invention provides a cleansing composition or a fabric and home care composition comprising the copolymer as described herein and at least one surfactant.
In the fourth aspect, the present invention provides a method of preserving an aqueous cleansing composition comprising the copolymer as described herein against microbial contamination or growth, which includes adding 2-phenoxyethanol in the detergent composition.
In the fourth aspect, the present invention provides a method of cleansing a fabric or a hard surface, which comprises an antimicrobial treatment of the fabric or the hard surface with a cleansing composition comprising the copolymer as described herein and 4, 4’-dichloro-2-hydroxydiphenylether.
The singular forms “a” , “an” and “the” include plural referents unless the context clearly dictates otherwise. The terms “comprise (s) ” , “comprising” , etc. are used interchangeably with “contain (s) ” , “containing” , etc. and are to be interpreted in a non-limiting, open manner. That is, e.g., further components or elements can be present. The expressions “consist (s) of” or “consisting of” or cognates can be embraced within “comprise (s) ” or “comprising” or cognates. The terms “include (s) ” , “including” , etc. are to be interpreted in a non-limiting, open manner.
Herein, in case of a (co) polymer or composition “comprises” the components or elements as mentioned, other components or elements may be comprised; in case of a (co) polymer or composition “consists essentially of” the components or elements as mentioned, it comprises mainly or almost only the mentioned components or elements and other components or elements in very minor amounts, and in case of a (co) polymer or composition “consist of” the components or elements as mentioned, it comprises only the mentioned components or elements and may possibly comprises impurities not avoidable in a technical environment.
Similarly, in case of any of the terms “substantially free of... ” , “substantially free from... ” and “ (comprising/containing) essentially no... ” is used herein, the term is intended to mean the indicated material is at the very minimum and not deliberately introduced into a (co) polymer or composition, or preferably is not present at an analytically detectable level. For example, the indicated material may be present, if at all, at a level of less than 1%, or even less than 0.1%, or even more less than 0.01%, or even 0%, by weight of the (co) polymer or composition.
The term “about” as used herein encompasses the exact number “X” mentioned as e.g., “about X%” etc., and small variations of X, including from minus 5 to plus 5%deviation from X (with X for this calculation set to 100%) , preferably from minus 2 to plus 2%, more preferably from minus 1 to plus 1%, even more preferably from minus 0.5 to plus 0.5%and smaller variations. Of course, if the value X given itself is already “100%” (such as for purity etc. ) then the term “about” clearly can and thus does only mean deviations thereof which are smaller than “100” .
The phrase “fabric and home care composition” is meant to include compositions and formulations designed for treating fabric. Such compositions include but are not limited to, laundry cleansing compositions and detergents, fabric softening compositions, fabric enhancing compositions, fabric freshening compositions, laundry prewash, laundry pretreat, laundry additives, spray products, dry cleansing agent or composition, laundry rinse additive, wash additive, post-rinse fabric treatment, ironing aid, unit dose formulation, delayed delivery formulation, detergent contained on or in a porous substrate or nonwoven sheet, and other suitable forms that may be apparent to one skilled in the art in view of the teachings herein and detailed herein below when describing the compositions. Such compositions may be used as a pre-laundering treatment, a post-laundering treatment, or may be added during the rinse or wash cycle of the laundering operation, and as further detailed herein below when describing the use and application of the copolymer according to the present invention and compositions comprising the copolymers.
Herein, any percentage given for a component of a composition is calculated in reference to the active ingredient thereof with exclusion of impurities which may be present in commercially available sources of such components (for example, residual solvents or by-products) , based on the weight of the total composition, unless otherwise specified. Also, all ratios are by weight, unless specified otherwise.
All temperatures herein are in degrees Celsius (℃) unless otherwise indicated. All measurements herein are conducted at 20℃ and under the atmospheric pressure unless otherwise specified.
In the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and optionally interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-,
- blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-,
provided that the ester linking units containing a moiety of -C (O) -O-are interrupted by the polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, when the blocks are derived from one ethylenically unsaturated comonomer.
Hereinbelow, the term “optionally interrupted ester linking units” will be used as an abbreviation for the ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and optionally interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-. In those optionally interrupted ester linking units, the moiety of -C (O) -O-optionally contains a polyoxyalkylene-carbonyl segment inserted between the carbonyl “-C (O) -” and the oxygen “-O-” , which may be represented by -C (O) -Gx-O-wherein G represents a polyoxyalkylene-carbonyl segment and x is 0 or 1.
Accordingly, the term “interrupted ester linking units” will be used as an abbreviation for the ester linking units containing a moiety of -C (O) -O-which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-. In such interrupted ester linking units, the moiety of -C (O) -O-contains a polyoxyalkylene-carbonyl segment inserted between the carbonyl “-C (O) -” and the oxygen “-O-” , which may be represented by -C (O) -G
x-O-wherein G represents a polyoxyalkylene-carbonyl segment and x 1.
The term “uninterrupted ester linking units” will be used as an abbreviation for the ester linking units containing a moiety of -C (O) -O-which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of-C (O) -O-.
In some embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and
- blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
In some other embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and
- blocks derived from two or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
Herein, the polyoxyalkylene-carbonyl segment refers to a segment containing a polyoxyalkylene chain and a carbonyl at the end of the polyoxyalkylene chain. The polyoxyalkylene-carbonyl segment may be represented by a general formula of
*-O-R- [O-R]
m- [O-R
1]
n- [O-R
2]
o-O-R
3-C (O) -
** (i)
wherein
R, R
1 and R
2 are independently of one another, a linear or branched C
2.12-alkylene, provided that any two of R, R
1 and R
2 in adjacent blocks are different from each other,
R
3 is a linear or branched C
1-11-alkylene,
m is a number of 1 or higher,
n and o are independently of one another, a number of 0 or higher,
* represents the bond to the carbonyl “-C (O) -” of the moiety of -C (O) -O-in the interrupted ester linking units, and
** represents the bond to the oxygen “-O-” of the moiety of -C (O) -O-in the interrupted ester linking units.
Particularly, the group -O-R
3-C (O) -in formula (I) represents an oxyalkylenecarbonyl group which corresponds to the closest one of -O-R
2-, -O-R
1-and -O-R-with the terminal methylene therein being replaced with a carbonyl group. For example, the group -O-R
3-C (O) -in formula (I) represents an oxyalkylenecarbonyl group which corresponds to -O-R
2-with the terminal methylene of R
2 being replaced with a carbonyl group, when the index o is a number of higher than zero. Alternatively, the group -O-R
3-C (O) -in formula (I) represents an oxyalkylenecarbonyl group which corresponds to -O-R
1-with the terminal methylene of R
1 being replaced with a carbonyl group, when the index o is zero and the index n is a number of higher than zero. Alternatively, the group -O-R
3-C (O) -in formula (I) represents an oxyalkylenecarbonyl group which corresponds to -O-R-with the terminal methylene of R being replaced with a carbonyl group, when both indices o and n are zero.
For example, the polyoxyalkylene-carbonyl segment is a polyoxyethylene-carbonyl segment (i.e., formula (I) in which R is ethylene, n and o are zero, and R
3 is -CH
2-) , a polyoxypropylene-carbonyl segment (i.e., formula (I) in which R is 1, 2-propylene, n and o are zero, and R
3 is 1, 1-ethylene) , a polyoxybutylene-carbonyl segment (i.e., formula (I) in which R is 1, 2-butylene, n and o are zero, and R
3 is propylidene) , poly (oxyethylene-oxypropylene) -carbonyl segment, poly (oxyethylene-oxypropylene-oxyethylene) -carbonyl segment, poly (oxyethylene-oxybutylene) -carbonyl segment, poly (oxyethylene-oxybutylene-oxyethylene) -carbonyl segment (i.e., formula (I) in which R is ethylene, R
1 is 1, 2-propylene and R
2 is ethylene, m, n and o are a number of 1 or higher and R
3 is -CH
2-) , and the like.
More preferably, the polyoxyalkylene-carbonyl segment is a polyoxyethylene-carbonyl segment of formula (I) in which R is ethylene, n and o are zero and R
3 is -CH
2-, or a polyoxypropylene-carbonyl segment of formula (I) in which R is 1, 2-propylene, n and o are zero and R
3 is 1, 1-ethylene. Most preferably, the polyoxyalkylene-carbonyl segment is a polyoxyethylene-carbonyl segment of formula (I) in which R is ethylene, n and o are zero, and R
3 is -CH
2-.
The polyoxyalkylene-carbonyl segment may have a number average molecular weight (Mn) in the range of 400 to 1500 g/mol, preferably 400 to 1200 g/mol, more preferably 400 to 800 g/mol. The optionally interrupted ester linking units may be represented by a general formula of
-CR
1R
2-C (O) -G
x-O-R
3- (II)
wherein
R
1 and R
2 are independently of one another, hydrogen or a linear or branched alkyl, for example linear or branched C
1-12-alkyl,
R
3 is a linear or branched alkylene, arylene, alkylarylene or arylalkylene, which is optionally interrupted by a heteroatom such as O, S and N, and preferably having 1 to 12 carbon atoms in each alkylene and alkyl moiety, and 5 to 12 ring atoms in each arylene and arylene moiety, -G-is a polyoxyalkylene-carbonyl segment of formula (I) as described hereinabove,
x is 0 or 1.
It will be understood that ester linking units which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted may be represented by the formula (II) in which x is 0; and ester linking units which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment may be represented by the formula (II) in which x is 1.
The cyclic ketene acetal from which the optionally interrupted ester linking units are derived is preferably selected from the group consisting of 2-methylene-1, 3-dioxepane (MDO) of formula (III) , 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) of formula (IV) , 2-methylene-1, 3, 6-trioxocane (MTC) of formula (V) , 5, 6-dialkyl-2-methylene-1, 3-dioxepane of formula (VI) , 2-methylene-1, 3-dioxolane of formula (VII) , and 4, 5-dialkyl-2-methylene-1, 3-dioxolane of formula (VIIII)
wherein R
4 and R
5 in formula (VI) and (VIII) are, independently of one another, a linear or branched alkyl, preferably C
1-12-alkyl group.
More preferably, the cyclic ketene acetal from which the optionally interrupted ester linking units are derived is selected from the group consisting of 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) , 2-methylene-1, 3-dioxepane (MDO) and 2-methylene-1, 3, 6-trioxocane (MTC) , most preferably 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) and 2-methylene-1, 3, 6-trioxocane (MTC) .
Suitable ethylenically unsaturated comonomers for deriving the blocks linked by the ester linking units containing a moiety of -C (O) -O-may be those endowing the copolymers with certain functional application properties. For example, ethylenically unsaturated comonomers suitable for the copolymers according to the present invention may include, but are not limited to, ethylenically unsaturated monocarboxylic acids and derivatives thereof such as salts, esters, anhydrides and amides, for example (meth) acrylic acid, alkyl (meth) acrylate, crotonic acid, N-methacryloyI-D-glucosamine, vinyl benzoic acid, vinylacetic acid, acrylamide, and methyl acrylamide; ethylenically unsaturated dicarboxylic acids and derivatives thereof such as salts, esters, anhydrides and amides, such as fumaric acid, maleic acid and maleic anhydride, itaconic acid and itaconic anhydride; ethylenically unsaturated alcohols such as allyl alcohol; ethylenically unsaturated amines such as allyl amine; vinyl lactams such as N-vinylpyrrolidinone; vinyl heterocyclic compounds such as N-vinyl imidazole and vinyl pyridine; vinyl ethers such as methyl vinyl ether; alkenyl carboxyalkyl ethers; vinyl esters of carboxylic acids such as vinyl formate, vinyl acetate, vinyl propionate, vinyl butyrate, vinyl isobutyrate, vinyl valerate, vinyl 2-ethylhexanoate, vinyl isooctanoate, vinyl nonoate, vinyl decanoate and vinyl pivalate; alkenyl aromatics such as vinyl benzene; alkenyl aldehydes such as acrolein; alkenyl nitriles such as acrylonitrile and methacrylonitrile; and olefins.
Preferably, the ethylenically unsaturated comonomer may be selected from the group consisting of (meth) acrylic acid, alkyl (meth) acrylates such as methyl (meth) acrylate and butyl (meth) acrylate, maleic acid, maleic acid anhydride, itaconic acid, itaconic anhydride, N-vinylpyrrolidinone, N-vinyl imidazole, vinyl esters such as vinyl acetate. More preferably, the ethylenically unsaturated comonomer may be selected from the group consisting of N-vinylpyrrolidinone and N-vinyl imidazole.
The blocks derived from one or more ethylenically unsaturated comonomers generally have an average number of repeating monomeric units in the range of 1 to 10, preferably 1 to 8, more preferably 1 to 5 per block.
In some embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and
- blocks derived from one or more, preferably one, ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of-C (O) -O-,
wherein the cyclic ketene acetal is selected from the group consisting of 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) , 2-methylene-1, 3-dioxepane (MDO) and 2-methylene-1, 3, 6-trioxocane (MTC) , and the one or more ethylenically unsaturated comonomers are selected from the group consisting of N-vinylpyrrolidinone and N-vinyl imidazole.
In the immediately above embodiments, the cyclic ketene acetal is preferably 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) or 2-methylene-1, 3, 6-trioxocane (MTC) , and the ethylenically unsaturated comonomer is preferably N-vinylpyrrolidinone or N-vinyl imidazole.
In some other embodiments according to the first aspect, the present invention provides a copolymer, which comprises
- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and
- blocks derived from two or more, preferably two, ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-,
wherein the cyclic ketene acetal is selected from the group consisting of 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) , 2-methylene-1, 3-dioxepane (MDO) and 2-methylene-1, 3, 6-trioxocane (MTC) , and the ethylenically unsaturated comonomers are N-vinylpyrrolidinone and N-vinyl imidazole.
In the immediately above embodiments, the cyclic ketene acetal is preferably 5, 6-benzo-2-methylene-1, 3-dioxepane (BMDO) or 2-methylene-1, 3, 6-trioxocane (MTC) .
Preferably, the copolymer in the first aspect has a uniform distribution of the optionally interrupted ester linking units between the blocks in polymeric backbones. The copolymerization of the cyclic ketene acetal and the one or more ethylenically unsaturated comonomers proceeds throughout the entire polymerization process, leading to a uniform or homogeneous incorporation of the optionally interrupted ester linking units. Statistically random copolymer architectures will thus be obtained. Uniform distribution of the optionally interrupted ester linking units is intended to mean substantially uniform or homogeneous incorporation of cyclic ketene acetal over the copolymers of the cyclic ketene acetal and the comonomers.
In the copolymer according to the present invention, the monomeric units originating from the cyclic ketene acetal and the monomeric units originating from the one or more ethylenically unsaturated comonomers may be present in a molar ratio in the range of 1 ∶ 1 to 1 ∶ 10, preferably 1 ∶ 1 to 1 ∶ 8, more preferably 1 ∶ 1 to 1 ∶ 5, most preferably 2∶ 5 to 1 ∶ 5. In other words, the cyclic ketene acetal and the one or more ethylenically unsaturated comonomers are polymerized at a molar ratio in the range of 1 ∶ 1 to 1 ∶ 10, preferably 1 ∶ 1 to 1 ∶ 8, more preferably 1∶ 1 to 1∶ 5, most preferably 2∶ 5 to 1∶ 5 during the preparation of the copolymer.
In some embodiments of the copolymer comprising the interrupted ester linking units, the monomeric units originating from the cyclic ketene acetal and the oxyalkylene monomeric units originating from the polyoxyalkylene-carbonyl segment may be present in a molar ratio in the range of 1∶ 5 to 1∶ 30, preferably 1∶ 8 to 1∶ 25, more preferably 1∶ 10 to 1∶ 20.
In the copolymer comprising the interrupted ester linking units, the interrupted ester linking units may account for at least 50%by mole, preferably 75%by mole, more preferably 85%by mole, most preferably 90%by mole or 95%by mole, based on the sum of the interrupted ester linking units and if present the uninterrupted ester linking units.
In some embodiments of the copolymer comprising the uninterrupted ester linking units, the monomeric units originating from the two or more ethylenically unsaturated comonomers may be present in any suitable molar ratios without particular restriction. For example, in the embodiments of the copolymer comprising the uninterrupted ester linking units and blocks derived from N-vinylpyrrolidinone and N-vinyl imidazole as the ethylenically unsaturated comonomers, the molar ratio of N-vinylpyrrolidinone to N-vinyl imidazole may be in the range of 10∶1 to 1∶ 2, preferably 6∶ 1 to 1∶ 2, most preferably 4∶ 1 to 1∶ 1.
In the copolymer comprising the uninterrupted ester linking units, the uninterrupted ester linking units may account for at least 50%by mole, preferably 75%by mole, more preferably 85%by mole, most preferably 90%by mole, 95%by mole, based on the sum of the uninterrupted ester linking units and if present interrupted ester linking units. Preferably, the uninterrupted ester linking units account for 100%by mole of the ester linking units containing a moiety of -C (O) -O-which have been derived from a cyclic ketene acetal via radical ring-opening polymerization.
In some embodiments of the copolymer comprising the uninterrupted ester linking units and the blocks derived from two or more ethylenically unsaturated comonomers linked by the ester linking units, the copolymer has a statistically random distribution of the blocks derived from each of ethylenically unsaturated comonomers over the polymeric backbone of the copolymer. For example, the copolymer has a hybrid architecture in form of -B
1-E-B
2-E-B
1-E-B
2-E-, wherein B
1 and B
2 represent the blocks derived from two ethylenically unsaturated comonomers respectively and E represents the ester linking units uninterrupted ester linking units.
The molar ratio of monomeric units as described herein can be determined by
1H NMR measurement.
The copolymers according to the present invention may have a number average molecular weight (Mn) in the range of from 1,000 to 50,000 g/mol, preferably from 2,000 to 30,000 g/mol, more preferably from 3,000 to 30,000 g/mol, still preferable from 3,000 to 10,000 g/mol or 3,000 to 6,000 g/mol, as measured by gel permeation chromatography (GPC) .
The copolymers according to the present invention are linear copolymers.
In the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes steps of
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester, or (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units,
wherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
Hereinbelow, the first and the second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units may be respectively referred to as the first unmodified copolymer and the second unmodified copolymer as abbreviations.
The first unmodified copolymer and the second unmodified copolymer may be commercially available, or may be prepared by free radical polymerization of a cyclic ketene acetal and an ethylenically unsaturated comonomer in accordance with conventional processes. During the radical polymerization, the cyclic ketene acetal will undergo ring-opening, i.e., radical ring-opening polymerization, and form ester linking units containing a moiety of -C (O) -O-, by which the blocks of the ethylenically unsaturated comonomer are linked. Suitable free radical initiators for the radical polymerization are any conventional ones, including for example acyl peroxides such as deacetyl peroxide, dibenzoyl peroxide and tert-butyl peroxy-2-ethylhexanoate; peroxides such as di-tert-butyl peroxide; percarbonates such as dicyclohexyl peroxydicarbonate; and azo compounds such as 2, 2’-azobis (isobutyronitrile) (AIBN) , 2, 2’-azobis (2, 4-dimethylvaleronitrile) , 1, 1’ -azobis (cyanocyclohexane) and 2, 2’-azobis (methylbutyronitrile) . Preferably, the free radical initiators are azo compounds such as 2, 2’-azobis (isobutyronitrile) (AIBN) , 2, 2’-azobis (2, 4-dimethylvaleron itrile) , 1, 1’-azobis (cyanocyclohexane) and 2, 2’-azobis (methylbutyronitrile) , more pererably 2’-azobis (isobutyronitrile) (AI BN) .
Any general description or any description with preference with respect to the cyclic ketene acetal, the ethylenically unsaturated comonomers, and monomeric ratios thereof are also applicable here for the polymers in the second aspect of the present invention.
The transesterification of the first unmodified copolymer with either (i) the polyalkylene oxide monocarboxylic acid polyester or (ii) the second unmodified copolymer may be carried out in accordance with any conventional process without particular restriction. For example, the transesterification may be carried out in the presence of a zinc catalyst under an inert atmosphere while heating, for example at a temperature of 120℃.
Herein, the polyalkylene oxide monocarboxylic acid polyester refers to a polyester of polyalkylene oxide monocarboxylic acid, which may be commercially available ones or may be prepared by any conventional process without any particular restriction. For example the polyalkylene oxide monocarboxylic acid polyester may be prepared by polycondensation of a polyalkylene oxide monocarboxylic acid. The polyalkylene oxide monocarboxylic acid may be commercially available ones or may be prepared by any known process, for example by oxidation of a polyalkylene oxide in the presence of a catalyst such as platinum (Pt) catalyst, as described for example in the PCT patent application No. PCT/EP2022/065984.
Particularly, the polyalkylene oxide monocarboxylic acid polyester is a polyester of polyethylene oxide monocarboxylic acid, a polyester of polyprepylene oxide monocarboxylic acid, a polyester of polyoxybutylene monocarboxylic acid, a polyester of poly (ethylene oxide-propylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-propylene oxide-ethylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-butylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-butylene oxide-ethylene oxide) monocarboxylic acid, and the like.
Preferably, the polyalkylene oxide monocarboxylic acid polyester is a polyester of polyethylene oxide monocarboxylic acid or a polyester of polypropylene oxide monocarboxylic acid, more preferably polyethylene oxide monocarboxylic acid.
The polyalkylene oxide monocarboxylic acid polyester may have a number average molecular weight (Mn) in the range of 2,000 to 20,000, preferably 4,000 to 15,000.
In some embodiments according to the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester.
It will be understood that polyoxyalkylene-carbonyl segments will be resulted from the polyalkylene oxide monocarboxylic acid polyester upon transesterification and thus be inserted between the ester linking units derived from the cyclic ketene acetal. In other words, upon the transesterification, a polyoxyalkylene-carbonyl segment, preferably a polyoxyalkylene-carbonyl segment as described in the first aspect, will be incorporated into the ester linking units derived from the cyclic ketene acetal. Particularly, the polyoxyalkylene-carbonyl segment is inserted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-in the ester linking units.
In some other embodiments according to the second aspect, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units,
wherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
Upon the transesterification, a modified copolymer having a hybrid architecture is resulted from the first and second unmodified copolymers. The hybrid architecture has a statistically random distribution of the blocks originating from each of the unmodified copolymers over the polymeric backbone of the modified copolymer.
In some preferable embodiments, the first unmodified copolymer and the second unmodified copolymer differ from each other in the ethylenically unsaturated comonomer forming the blocks.
In some particular embodiments, the present invention provides a process for preparing a copolymer, preferably the copolymer as described herein, which includes
(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from a first ethylenically unsaturated comonomer and linked by the ester linking units, and
(b) subjecting the first unmodified copolymer to transesterification with (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from second ethylenically unsaturated comonomer and linked by the ester linking units,
wherein the first unmodified copolymer and the second unmodified copolymer comprise the same ester linking units derived from a cyclic ketene acetal.
In the immediately above particular embodiments, the hybrid architecture is in form of -B
1-E-B
2-E-B
1-E-B
2-E-, wherein B
1 and B
2 represent the blocks originating from the first and second unmodified copolymers respectively and E represents the same ester linking units originating from the first and second unmodified copolymers.
It can be contemplated that a modified copolymer having a hybrid architecture may also be obtained from three or more different unmodified copolymers by transesterification, each comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and being different from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
It was surprisingly found by the inventors that the copolymers as described in the first aspect or the copolymers obtained/obtained from the process as described in the second aspect have a good biodegradability, and also application properties such as anti-adhesive property, dye-transfer inhibition property and compatibility with biocides.
The copolymers as described herein may be used in cleansing compositions such as laundry detergent compositions and industrial and institutional cleansing compositions, fabric and home care compositions, cosmetic or personal care compositions, oil field-formulations such as crude oil emulsion breaker, inks, electro plating compositions, cementitious compositions, lacquers or paints, and agrochemical formulations, preferably in laundry detergent compositions, and in fabric and home care compositions.
Therefore, in the third aspect, the present invention provides a cleansing composition or a fabric and home care composition comprising the copolymer as described herein and at least one surfactant.
The term “cleansing composition” as used herein includes compositions and formulations designed for cleansing any soiled material, which includes, but are not limited to laundry detergent compositions, industrial and institutional cleansing compositions for use of cleansing for example hard surfaces such as tiles, carpets, PVC-surfaces, wooden surfaces, metal surfaces, lacquered surfaces. The term “fabric and home care compositions” includes for example fabric softening compositions, fabric enhancing compositions, fabric freshening compositions, laundry prewash, laundry pretreat, laundry additives, spray products, dry cleansing compositions, laundry additives, laundry rinse additives, wash additives, post-rinse fabric treatment compositions, ironing aids, dish washing compositions, hard surface cleansing compositions, unit dose formulations, delayed delivery formulations, detergents contained on or in a porous substrate or nonwoven sheet, light-duty and heavy-duty liquid detergent compositions, bleaching compositions.
Various types of cleansing compositions and fabric and home care compositions are known in the art. Any conventional formulations of those compositions may be applied with including at least one copolymer according to the present invention. The copolymer according to the present invention may be used in those compositions in addition to or in place of an active or additive ingredient having a similar functional property.
In some embodiments, the present invention provides a laundry detergent composition and a fabric and home care composition comprising the copolymer as described herein and at least one surfactant, preferably a liquid laundry detergent composition such as a laundry care composition or a laundry washing composition, or a liquid fabric and home care composition.
The copolymer according to the present invention may be present in a cleansing composition or a fabric and home care composition in an amount in the range of 0.01%to 20%, preferably 0.05%to 15%, more preferably 0.1%to 10%, and most preferably 0.5%to 5%, based on the total weight of the composition. The composition may further comprise 1%to 70%by weight of the surfactant.
There is no particular restriction to the surfactant useful for the present invention, which may be selected from anionic surfactants, cationic surfactants, non-ionic surfactants, amphoteric surfactants, zwitterionic surfactants and any combinations thereof.
Nonlimiting examples of anionic surfactants may include C
9-C
20 linear alkylbenzene sulfonates (LAS) , C
10-C
20 primary, branched chain and random alkyl sulfates (AS) ; C
10-C
18 secondary (2, 3) alkyl sulfates of the formula CH
3 (CH
2)
x (CHOSO
3
-M
+) CH
3 and CH
3 (CH
2)
y (CHOSO
3
-M
+) CH
2CH
3 where x and (y+1) are integers of at least about 7 and M is a water-solubilizing cation; unsaturated sulfates such as oleyl sulfate; C
10-C
18 alkyl alkoxy sulfates (AExS) wherein x is from 1 to 30; C
10-C
18 alkyl alkoxy carboxylates comprising 1 to 5 ethoxy units; mid-chain branched alkyl sulfates as described in US 6,020,303 and US 6,060,443; mid-chain branched alkyl alkoxy sulfates as described in US 6,008,181 and US 6,020,303; modified alkylbenzene sulfonate (MLAS) as described in WO 99/05243, WO 99/05242 and WO 99/05244; methyl ester sulfonate (MES) ; and alpha-olefin sulfonate (AOS) .
Preferable examples of suitable anionic surfactants are alkali metal and ammonium salts of C
8-C
12-alkyl sulfates, of C
12-C
18-fatty alcohol ether sulfates, of C
12-C
18-fatty alcohol polyether sulfates, of sulfuric acid half-esters of ethoxylated C
4-C
12-alkylphenols (ethoxylation: 3 to 50 mol of ethylene oxide/mol) , of C
12-C
18-alkylsulfonic acids, of C
12-C
18 sulfo fatty acid alkyl esters, for example of C
12-C
18 sulfo fatty acid methyl esters, of C
10-C
18-alkylarylsulfonic acids, preferably of n-C
10-C
1s-alkylbenzene sulfonic acids, of C
10-C
18 alkyl alkoxy carboxylates and of soaps such as for example C
8-C
24-carboxylic acids. Preference is given to the alkali metal salts of the aforementioned compounds, particularly preferably the sodium salts.
For example, an anionic surfactant selected from C
10-C
15-linear alkylbenzenes sulfonates, C
10-C
18-alkylether sulfates with 1 to 5 ethoxy units and C
10-C
18-alkylsulfates may be used.
The cleansing composition or the fabric and home care composition may comprise one or more anionic surfactants in an amount in the range of 1%to 50%, preferably 2%to 30%, more preferably 3%to 25%, and most preferably 5%to 25 %, based on the total weight of the composition.
Non-limiting examples of non-ionic surfactants may include C
8-C
18 alkyl ethoxylates, such as
non-ionic surfactants from Shell; ethylenoxide/propylenoxide block alkoxylates, such as
from BASF; C
14-C
22 mid-chain branched alkyl alkoxylates, BAEx, wherein x is from 1 to 30, as described in US 6,153,577, US 6,020,303 and US 6,093,856; alkylpolysaccharides as described in U.S. 4,565,647; specifically alkylpolyglycosides as described in US 4,483,780 and US 4,483,779; polyhydroxy fatty acid amides as described in US 5,332,528; and ether capped poly (oxyalkylated) alcohol surfactants as described in US 6,482,994 and WO 01/42408.
The non-ionic surfactants are in particular alkoxylated alcohols and alkoxylated fatty alcohols, di-and multiblock copolymers of ethylene oxide and propylene oxide and reaction products of sorbitan with ethylene oxide or propylene oxide, furthermore alkylphenol ethoxylates, alkyl glycosides, polyhydroxy fatty acid amides (glucamides) .
Preferably, the non-ionic surfactants may be selected from C
12/14 and C
16/18 fatty alkoholalkoxylates, C
13/15 oxoalkoholalkoxylates, C
13-alkoholalkoxylates, and 2-propylheptylalkoholalkoxylates, each having 3 to 15 ethoxy units, preferably 5 to 10 ethoxy units, or having 1 to 3 propoxy-and 2 to 15 ethoxy units.
The cleansing composition or the fabric and home care composition may comprise one or more non-ionic surfactants in an amount in the range of 1%to 50%, preferably 2%to 40%, more preferably 3%to 30%, and most preferably 5%to 25 %, based on the total weight of the composition.
Non-limiting examples of amphoteric surfactants may include water-soluble amine oxides and water-soluble sulfoxides, especially water-soluble amine oxides. Preferred amine oxides are alkyl dimethyl amine oxides and alkyl amido propyl dimethyl amine oxides, more preferably coco dimethyl amino oxide and coco amido propyl dimethyl amine oxide. Amine oxides may have a linear or mid-branched alkyl moiety.
Typical linear amine oxides include water-soluble amine oxides containing one C
8-C
18-alkyl moiety and two moieties selected from C
1-C
3-alkyl groups and C
1-C
3-hydroxyalkyl groups. The amine oxides of formula R
1-N (R
2) (R
3) O in which R
1 is a C
8-C
18-alkyl and R
2 and R
3 are selected from methyl, ethyl, propyl, isopropyl, 2-hydroxethyl, 2-hydroxypropyl and 3-hydroxypropyl. The linear amine oxide surfactants in particular may include linear C
10-C
18-alkyl dimethyl amine oxides and linear C
8-C
12-alkoxy ethyl dihydroxy ethyl amine oxides.
Typical mid-branched amine oxides have one alkyl moiety having n
1 carbon atoms and one alkyl branch having n
2 carbon atoms wherein the alkyl branch is located on the α or β carbon from the nitrogen. This type of branching for the amine oxide is also known in the art as an internal amine oxide. The sum of n
1 and n
2 is in the range of 10 to 24, preferably from 12 to 20, and more preferably 10 to 16. The number of carbon atoms for the one alkyl moiety (n
1) should be approximately the same number of carbon atoms as the one alkyl branch (n
2) such that the one alkyl moiety and the one alkyl branch are symmetric. Here “symmetric” means that (n
1-n
2) is less than or equal to 5, preferably 4, most preferably from 0 to 4 carbon atoms in at least 50 wt%, more preferably at least 75 wt%to 100 wt%of the mid-branched amine oxides. The amine oxide further comprises two moieties, independently selected from a C
1-C
3-alkyl, a C
1-C
3-hydroxyalkyl group, or a polyethylene oxide group containing an average of 1 to 3 ethylene oxide groups.
Preferably, the amphoteric surfactants may be selected from C
8-18-alkyl dimethyl aminoxides and C
8-C
18-alkyl di (hydroxyethyl) aminoxide.
Non-limiting examples of zwitterionic surfactants may include betaines such as alkyl betaines, alkylamidobetaines, amidazoliniumbetaines, sulfobetaines (INCI Sultaines) as well as phosphobetaines. Preferred betaines are, for example alkylbetaines and sulfobetaines. Examples of suitable alkylbetaines and sulfobetaines include (designated in accordance with INCI) : Almondamidopropyl Betaines, Apricotamidopropyl Betaines, Avocadamidopropyl Betaines, Babassuamidopropyl Betaines, Behenamidopropyl Betaines, Behenyl Betaines, Canolamidopropyl Betaines, Capryl/Capramidopropyl Betaines, Carnitine, Cetyl Betaines, Cocamidoethyl Betaines, Cocamidopropyl Betaines, Cocamidopropyl Hydroxysultaine, Coco-Betaines, Coco-Hydroxysultaine, Coco/Oleamidopropyl Betaines, Coco-Sultaine, Decyl Betaines, Dihydroxyethyl Oleyl Glycinate, Dihydroxyethyl Soy Glycinate, Dihydroxyethyl Stearyl Glycinate, Dihydroxyethyl Tallow Glycinate, Dimethicone Propyl PG-Betaines, Erucamidopropyl Hydroxysultaine, Hydrogenated Tallow Betaines, Isostearamidopropyl Betaines, Lauramidopropyl Betaines, Lauryl Betaines, Lauryl Hydroxysultaine, Lauryl Sultaine, Milkamidopropyl Betaines, Minkamidopropyl Betaines, Myristamidopropyl Betaines, Myristyl Betaines, Oleamidopropyl Betaines, Oleamidopropyl Hydroxysultaine, Oleyl Betaines, Olivamidopropyl Betaines, Palmamidopropyl Betaines, Palmitamidopropyl Betaines, Palmitoyl Carnitine, Palm Kernelamidopropyl Betaines, Polytetrafluoroethylene Acetoxypropyl Betaines, Ricinoleamidopropyl Betaines, Sesamidopropyl Betaines, Soyamidopropyl Betaines, Stearamidopropyl Betaines, Stearyl Betaines, Tallowamidopropyl Betaines, Tallowamidopropyl Hydroxysultaine, Tallow Betaines, Tallow Dihydroxyethyl Betaines, Undecylenamidopropyl Betaines And Wheat Germamidopropyl Betaines.
Non-limiting examples of cationic surfactants may include quaternary ammonium surfactants, which can have up to 26 carbon atoms, for example alkoxylated quaternary ammonium (AQA) surfactants as described in US 6,136,769; dimethyl hydroxyethyl quaternary ammonium as described in US 6,004,922; dimethyl hydroxyethyl lauryl ammonium chloride; polyamine cationic surfactants as described in WO 98/35002, WO 98/35003, WO 98/35004, WO 98/35005, and WO 98/35006; cationic ester surfactants as described in US patents Nos. 4,228,042, 4,239,660 4,260,529 and US 6,022,844; and amino surfactants as described in US 6,221,825 and WO 00/47708, specifically amido propyldimethyl amine (APA) .
The compositions of the invention may comprise adjunct additives (also abbreviated herein as “adjuncts” ) , such adjuncts being preferably in addition to the surfactant as described hereinabove.
Suitable adjuncts may include builders, fatty acids and/or salts thereof, structurants, thickeners and rheology modifiers, clay/soil removal/anti-redeposition agents, polymeric soil release agents, dispersants such as polymeric dispersing agents, polymeric grease cleansing agents, solubilizing agents, amphiphilic copolymers, chelating agents, enzymes, enzyme stabilizing systems, encapsulated benefit agents such as encapsulated perfume, bleaching compounds, bleaching agents, bleach activators, bleach catalysts, catalytic materials, brighteners, malodor control agents, pigments, dyes, opacifiers, pearlescent agents, hueing agents, dye transfer inhibiting agents, fabric softeners, carriers, suds boosters, suds suppressors (antifoams) , color speckles, silver care, anti-tarnish and/or anti-corrosion agents, alkalinity sources, pH adjusters, pH-buffer agents, hydrotropes, scrubbing particles, anti-bacterial and anti-microbial agents, preservatives, anti-oxidants, softeners, carriers, fillers, solvents, processing aids, pro-perfumes, and perfumes.
In the context of the present invention, no distinction will be made between builders and such components elsewhere called “co-builders” . Examples of builders include complexing agents, ion-exchange compounds, dispersing agents, scale inhibiting agents and precipitating agents.
Builders may be selected from citrates, phosphates, silicates, carbonates, phosphonates, amino carboxylates and polycarboxylates.
Suitable citrates include mono-, di-and tri-alkali metal salts of citric acid, ammonium or substituted ammonium salts of citric acid, as well as citric acid. Citrates can be used as the anhydrous compound or as a hydrate, for example as trisodium citrate dihydrate. Any amount of citrates, when used, is calculated referring to anhydrous trisodium citrate.
Suitable phosphates include sodium metaphosphate, sodium orthophosphate, sodium hydrogenphosphate, sodium pyrophosphate and polyphosphates such as sodium tripolyphosphate. However, it is preferred that the compositions according to the invention is free from phosphates, polyphosphates, and hydrogenphosphates.
Suitable silicates include sodium disilicate and sodium metasilicate, aluminosilicates such as for example zeolites and sheet silicates, in particular those of the formula α-Na
2Si
2O
5, β-Na
2Si
2O
5, and δ-Na
2Si
2O
5.
Suitable carbonates include alkali metal carbonates and alkali metal hydrogen carbonates, preferably sodium salts.
Suitable phosphonates are hydroxyalkanephosphonates and aminoalkanephosphonates. Among the hydroxyalkanephosphonates, 1-hydroxyethane-1, 1-diphosphonate (HEDP) is of particular importance as the builder. It is preferably used as sodium salt, the disodium salt being neutral and the tetrasodium salt being alkaline (pH 9) . Suitable aminoalkanephosphonates are preferably ethylene diaminetetramethylenephosphonate (EDTMP) , diethylenetriaminepenta-methylenephosphonate (DTPMP) , and also their higher homologues. The phosphonates are preferably used in the form of the neutrally reacting sodium salts, e.g. as hexasodium salt of EDTMP or as hepta-and octa-sodium salts of DTPMP.
Suitable amino carboxylates and polycarboxylates are nitrilotriacetates, ethylene diamine tetraacetate, diethylene triamine pentaacetate, triethylenetetraamine hexaacetate, propylene diamine tetraacetic acid, ethanol-diglycines, methylglycine diacetate, and glutamine diacetate. The amino carboxylates and polycarboxylates are preferably used in the form of respective non-substituted or substituted ammonium salts and the alkali metal salts such as the sodium salts, in particular in respective fully neutralized salts form.
The compositions according to the invention may comprise an alkali carrier. The alkali carrier can ensure, for example, a pH of at least 9 if an alkaline pH is desired. Suitable alkali carriers are for example, alkali metal carbonates, alkali metal hydrogen carbonates, and alkali metal metasilicates, and alkali metal hydroxides. Preferably the alkali metal is potassium in each case, more preferably sodium. In the present invention, a pH >7 may also be adjusted by using amines, preferably alkanolamines, more preferably triethanolamine.
The compositions according to the present invention may comprise an enzyme, preferably a detergent enzyme.
In one embodiment, the enzyme is classified as an oxidoreductase (EC 1) , a transferase (EC 2) , a hydrolase (EC 3) , a lyase (EC 4) , an isomerase (EC 5) , or a ligase (EC 6) . The EC-numbering is according to Enzyme Nomenclature, Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology including its supplements published 1993-1999. Preferably, the enzyme is a hydrolase (EC 3) .
The enzyme may be selected from proteases, amylases, lipases, cellulases, mannanases, hemicellulases, phospholipases, esterases, pectinases, lactases, peroxidases, xylanases, cutinases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, beta-glucanases, arabinosidases, hyaluronidases, chondroitinases, laccases, nucleases, DNase, phosphodiesterases, phytases, carbohydrases, galactanases, xanthanases, xyloglucanases, oxidoreductase, perhydrolases, aminopeptidase, asparaginase, carbohydrase, carboxypeptidase, catalase, chitinase, cyclodextrin glycosyltransferase, alpha-galactosidase, beta-galactosidase, glucoamylase, alpha-glucosidase, beta-glucosidase, invertase, ribonuclease, transglutaminase, and dispersins, and combinations of at least two of the foregoing types. More preferably, the enzyme is selected from the group consisting of proteases, amylases, lipases, cellulases, mannanases, xylanases, DNases, dispersins, pectinases, oxidoreductases, and cutinases, and combinations of at least two of the foregoing types. Most preferably, the enzyme is a protease, preferably, a serine protease, more preferably, a subtilisin protease.
Preferably, the protease is a protease with at least 90%sequence identity to SEQ ID NO: 22 of EP1921147B1 and having the amino acid substitution R101E (according to BPN’ numbering) . Preferably, the amylase is an amylase with at least 90%sequence identity to SEQ ID NO: 54 of WO2021032881A1.
The composition of the present invention can comprise one type of enzyme or more than one enzyme of different types, e.g., an amylase and a protease, or more than one enzyme of the same type, e.g., two or more different proteases, or mixtures thereof, e.g., an amylase and two different proteases.
The enzyme, when present, may be present in the compositions according to the present invention in an amount sufficient to provide an effective amount for achieving a beneficial effect, preferably for primary washing effects and/or secondary washing effects, like antigreying or antipilling effects (e.g., in case of cellulases) . Preferably, the enzyme may be present in an amount of 0.00001%to 5%, preferably 0.00001%to 2%, more preferably 0.0001%to 1%, or even more preferably 0.001%to 0.5%enzyme protein based on the total weight of the compositions.
Preferably, an enzyme-containing compositions may further comprise an enzyme stabilizing system. The enzyme-containing composition may comprise 0.001%to 10%, 0.005%to 8%, or 0.01%to 6%of an enzyme stabilizing system, based on the total weight of the compositions. The enzyme stabilizing system can be any stabilizing system which is compatible with the enzyme.
Preferably, the enzyme stabilizing system comprises at least one compound selected from the group consisting of polyols (preferably, ethylene glycol, 1, 2-propanediol, 1, 3-propanediol, glycerol or sorbitol) , salts (preferably, CaCl
2, MgCl
2 or NaCl) , short chain (preferably, C
1-C
6) carboxylic acids or salts thereof (preferably, formic acid, formate (preferably, sodium formate) , acetic acid, acetate, or lactate) , borate, boric acid, boronic acids (preferably, 4-formyl phenylboronic acid (4-FPBA) ) , peptide aldehydes, peptide acetals, and peptide aldehyde hydrosulfite adducts. Preferably, the enzyme stabilizing system comprises a combination of at least two of the compounds selected from the group consisting of salts, polyols, and short chain carboxylic acids and preferably one or more of the compounds selected from the group consisting of borate, boric acid, boronic acids (preferably, 4-formyl phenylboronic acid (4-FPBA) ) , peptide aldehydes, peptide acetals, and peptide aldehyde hydrosulfite adducts. In particular, if proteases are present in the composition, protease inhibitors may be added, preferably selected from borate, boric acid, boronic acids (preferably, 4-FPBA) , peptide aldehydes (preferably, peptide aldehydes like Z-VAL-H or Z-GAY-H) , peptide acetals, and peptide aldehyde hydrosulfite adducts.
The compositions according to the invention may further comprise a bleaching agent, which is preferably selected from sodium perborate, anhydrous or as the monohydrate or as the tetrahydrate or as the so-called dihydrate, sodium percarbonate, anhydrous or as the monohydrate, and sodium persulfate.
The compositions according to the invention may further comprise a bleach catalyst, which is preferably selected from oxaziridinium-based bleach catalysts, bleach-boosting transition metal salts or transition metal complexes such as, for example, manganese-, iron-, cobalt-, ruthenium-or molybdenum-salen complexes or carbonyl complexes. Manganese, iron, cobalt, ruthenium, molybdenum, titanium, vanadium and copper complexes with nitrogen-containing tripod ligands and also cobalt-, iron-, copper-and ruthenium-amine complexes can also be used as bleach catalysts.
The compositions according to the invention can comprise a bleach activator, for example tetraacetyl ethylene diamine, tetraacetylmethylene diamine, tetraacetylglycoluril, tetraacetylhexylene diamine, acylated phenolsulfonates such as for example n-nonanoyl-or isononanoyloxybenzene sulfonates, N-methylmorpholinium-acetonitrile salts ( “MMA salts” ) , trimethylammonium acetonitrile salts, N-acylimides such as, for example, N-nonanoylsuccinimide, 1, 5-diacetyl-2, 2-dioxohexahydro-1, 3, 5-triazine ( “DADHT” ) or nitrile quats (trimethylammonium acetonitrile salts) .
The compositions according to the invention may comprise a corrosion inhibitor, for example selected from triazoles, in particular benzotriazoles, bisbenzotriazoles, aminotriazoles, alkylaminotriazoles, also phenol derivatives such as, for example, hydroquinone, pyrocatechol, hydroxyhydroquinone, gallic acid, phloroglucinol or pyrogallol.
The compositions according to the invention may comprise other cleansing polymers and/or soil release polymers and/or anti-graying polymers.
The additional cleansing polymers may include, without limitation, “multifunctional polyethylene imines” (for example BASF’s
HP20) and/or “multifunctional diamines” (for example BASF’s
HP96) .
Suitable multifunctional polyethylene imines are typically ethoxylated polyethylene imines with a weight-average molecular weight Mw in the range from 3,000 to 250,000, preferably 5,000 to 200,000, more preferably 8,000 to 100,000, more preferably 8,000 to 50,000, more preferably 10,000 to 30,000, and most preferably 10,000 to 20,000 g/mol. Suitable multifunctional polyethylene imines have 80 wt%to 99 wt%, preferably 85 wt%to 99 wt%, more preferably 90 wt%to 98 wt%, most preferably 93 wt%to 97 wt%or 94 wt%to 96 wt%ethylene oxide side chains, based on the total weight of the materials. Ethoxylated polyethylene imines are typically based on a polyethylene imine core and a polyethylene oxide shell. Suitable polyethylene imine core molecules are polyethylene imines with a weight-average molecular weight Mw in the range of 500 to 5,000 g/mol. Preferably employed is a molecular weight from 500 to 1,000 g/mol, even more preferred is a Mw of 600 to 800 g/mol. The ethoxylated polymer then has on average 5 to 50, preferably 10 to 35 and even more preferably 20 to 35 ethylene oxide (EO) units per NH-functional group.
Suitable multifunctional diamines are typically ethoxylated C
2-C
12-alkylene diamines, preferably hexamethylene diamine, which are further quaternized and optionally sulfated. Typical multifunctional diamines have a weight-average molecular weight Mw in the range from 2,000 to 10,000, more preferably 3,000 to 8,000, and most preferably 4,000 to 6,000 g/mol. Particularly, ethoxylated hexamethylene diamine, furthermore quaternized and sulfated, may be employed, which contains on average 10 to 50, preferably 15 to 40 and even more preferably 20 to 30 ethylene oxide (EO) groups per NH-functional group, and which preferably bears two cationic ammonium groups and two anionic sulfate groups.
Suitable anti-graying polymers include copolymers of acrylic or maleic acid and styrene, graft polymers of acrylic acid onto maltodextrin or carboxymethylated cellulose and their alkali metal salts, in particular sodium salts thereof.
The compositions according to the present invention may also comprise a complexing agent, which is preferably selected from methylglycinediacetic acid (MGDA) and glutamic acid diacetic acid (GLDA) and salts thereof. MGDA and GLDA may be present as racemate or as enantiomerically pure compounds. GLDA is preferably selected from L-GLDA or enantiomerically enriched mixtures of L-GLDA in which at least 80 mol%, preferably at least 90 mol%, of L-GLDA is present. Suitable salts ara ammonium salts and alkali metal salts, particularly preferably potassium and in particular sodium salts.
The compositions according to the present invention may also comprise an antimicrobial agent and/or preservative. An antimicrobial agent is a chemical compound that kills microorganisms or inhibits their growth or reproduction. Microorganisms can be bacteria, yeasts or molds. A preservative is an antimicrobial agent which may be added to aqueous products and compositions to maintain the original performance, characteristics and integrity of the products and compositions by killing contaminating microorganisms or inhibiting their growth. Examples of preservatives ara as listed on pages 35 to 39 in patent application WO2021/115912 A1.
Especially of interest are the following antimicrobial agents and/or preservatives:
● 4, 4’-Dichloro-2-hydroxydiphenyl ether (Synonyms: 5-chloro-2- (4-chlorophenoxy) phenol, Diclosan, DCPP) ;
● 2-Phenoxyethanol (Synonyms: Phenoxyethanol, Methylphenylglycol, Phenoxetol, ethylene glycol phenyl ether, Ethylene glycol monophenyl ether, 2- (phenoxy) ethanol, 2-phenoxy-1-ethanol) ;
● 2-Bromo-2-nitropropane-1, 3-diol (Synonyms: 2-bromo-2-nitro-1, 3-propanediol, Bronopol) ;
● glutaraldehyde (Synonyms: 1, 5-pentandial, pentane-1, 5-dial, glutaral, glutardialdehyde) ;
● Glyoxal (Synonyms: ethandial, oxylaldehyde, 1, 2-ethandial) ;
● 2-Butyl-benzo [d] isothiazol-3-one (BBIT) ;
● 2-Methyl-2H-isothiazol-3-one (MIT) ;
● 2-Octyl-2H-isothiazol-3-one (OIT) ;
● 5-Chloro-2-methyl-2H-isothiazol-3-one (CIT or CMIT) ;
● Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (CMIT) and 2-methyl-2H-isothiazol-3-one (MIT) (Mixture of CMIT/MIT) ;
● 1, 2-benzisothiazol-3 (2H) -one (BIT) ;
● Hexa-2, 4-dienoic acid (trivial name “sorbic acid” ) and its salts, e.g., calcium sorbate, sodium sorbate; potassium (E, E) -hexa-2, 4-dienoate (Potassium Sorbate) ;
● Lactic acid and its salts; L- (+) -Iactic acid; especially sodium lactate;
● Benzoic acid and salts of benzoic acid, e.g., sodium benzoate, ammonium benzoate, calcium benzoate, magnesium benzoate, MEA-benzoate, potassium benzoate;
● Salicylic acid and its salts, e.g., calcium salicylate, magnesium salicylate, MEA salicylate, sodium salicylate, potassium salicylate, TEA salicylate;
● Benzalkonium chloride, benzalkonium bromide, benzalkonium saccharinate;
● Didecyldimethylammonium chloride (DDAC) ;
● N- (3-aminopropyl) -N-dodecylpropane-1, 3-diamine (Diamine) ;
● Peracetic acid; and
● Hydrogen peroxide.
The compositions according to the invention may comprise the at least one antimicrobial agent or preservative in an amount of 0.0001 to 10%, based on the total weight of the compositions.
Preferably, the compositions according to the invention may comprise 2-phenoxyethanol in an amount of 2 ppm to 5%, preferably 0.1%to 2%, or 4, 4’-dichloro 2-hydroxydiphenyl ether (DCPP) in an amount of 0.001%to 3%, preferably 0.002%to 1%, more preferably 0.01%to 0.6%, based on the total weight of the compositions.
Preferably, the compositions according to the invention may comprise 4, 4’-dichloro-2-hydroxydiphenylether, preferably in an amount of 0.001 to 3%, preferably 0.002 to 1%, more preferably 0.01 to 0.6%, based on the total weight of the compositions.
The compositions according to the invention may also comprise water and/or additional organic solvents, e.g., ethanol or propylene glycol, and/or fillers such as sodium sulfate.
Further optional ingredients may include, but are not limited to, viscosity modifiers, cationic surfactants, foam boosting or foam reducing agents, perfumes, dyes, optical brighteners, and dye transfer inhibiting agents.
In the fourth aspect, the present invention provides a method of preserving an aqueous cleansing composition comprising the copolymer as described herein against microbial contamination or growth, which includes adding 2-phenoxyethanol in the detergent composition.
In the fifth aspect, the present invention provides a method of cleansing a fabric or a hard surface, which includes an antimicrobial treatment of the fabric or the hard surface with a cleansing composition comprising the copolymer as described herein and 4, 4’-dichloro-2-hydroxydiphenylether.
Aspects of the present invention will be more fully illustrated by the following examples, which are set forth to illustrate certain aspects of the present invention and are not to be construed as limiting thereof.
Examples
Materials:
NVP: N-Vinylpyrrolidinone, Sigma-Aldrich, 98.0%.
NVI: N-vinyl imidazole, Sigma-Aldrich, 99.0%.
Recrystallized AIBN: 2’-azobis (isobutyronitrile) , Sigma-Aldrich.
MTC: 2-methylene-1, 3, 6-trioxocane, which was prepared by the process as described hereinbelow.
BMDO: 5, 6-benzo-2-methylene-1, 3-dioxepane, which was prepared by the process as described hereinbelow.
PEG monocarboxylic acid polyester: polyester of PEG-600 monocarboxylic acid, which was prepared by the process as described hereinbelow.
I. Preparation of Starting Materials
1. Preparation of MTC
Step 1.1 Synthesis of 2- (bromomethyl) -1, 3, 6-trioxocane
Diethylene glycol (Sigma-Aldrich, 98.0%, 126.8 g, 1.20 mol) , bromoacetaldehyde dimethylacetal (Sigma-Aldrich, 99.0%, 202.0 g, 1.20 mol) were mixed as a stock solution. Dioxane (Sigma-Aldrich, 98.0%, 330 g) and p-toluenesulfonic acid (Sigma-Aldrich, 98.0%, 1.14 g, 10 mmol) were added to a pre-dried three-neck flask fitted with a Claisen bridge and dropping funnel for collecting methanol, and heated to a temperature of 100 ℃, with the stock solution being added dropwise over 5 h under nitrogen. Methanol was removed while keeping effectively recycling dioxane. When almost the calculated amount of methanol was collected, the temperature was raised to 120 ℃ under a reduced pressure. After cooling to room temperature, the crude product was dissolved in CHCl
2 and washed with a NaHCO
3 solution and water. The solution was then dried over MgSO
4, concentrated, and distilled under a reduced pressure to give 110.0 g product, which was solidified into white crystals.
Step 1.2 Synthesis of MTC from 2- (bromomethyl) -1, 3, 6-trioxocane
2- (Bromomethyl) -1, 3, 6-trioxocane (110.0 g, 0.52 mol) was dissolved in 600 mL THF (Sigma-Aldrich, 98.0%) in a round-bottom flask. The flask was placed in an ice bath at 0 ℃ before t-BuOK (Sigma-Aldrich, 95.0%, 65.1 g, 0.68 mol) was slowly added over 6 h. The mixture was allowed to thaw to room temperature and continue to react under nitrogen for 24 h. Then the reaction mixture was poured into 2 L of diethyl ether. The insoluble material was removed by passing through Al
2O
3. The diethyl ether was removed, and the crude liquid was distilled under a reduced pressure to give a colorless liquid (30.0 g) .
2. Preparation of BMDO
Step 2.1: Synthesis of 5, 6-benzo-2- (bromomethyl) -1, 3-dioxepane
1, 2-benzenedimethanol (Sigma-Aldrich, 99.0%, 147.1 g, 1.06 mol) , bromoacetaldehyde dimethylacetal (Sigma-Aldrich, 99.0%, 180.0 g, 1.06 mol) were mixed as a stock solution. Dioxane (Sigma-Aldrich, 98.0%, 330 g) and p-toluenesulfonic acid (Sigma-Aldrich, 98.0%, 1.01 g, 10 mmol) were added to a pre-dried three-neck flask fitted with a Claisen bridge and dropping funnel for collecting methanol, and heated to a temperature to 100 ℃, with the stock solution dropwise being added over 5 h under nitrogen. Methanol was removed while keeping effectively recycling dioxane. When almost the calculated amount of methanol was collected, the temperature was raised to 120 ℃ under a reduced pressure. After cooling to room temperature, the crude product solidified. The product was dissolved in CHCl
2 and washed with a NaHCO
3 solution and water. The solution was then dried over MgSO
4, concentrated, and recrystallized in a mixture of chloroform and n-hexane to give 180.0 g of pale-yellow crystals.
Step 2.2: Synthesis of BMDO from 5, 6-benzo-2- (bromomethyl) -1, 3-dioxepane
A mixture of 5, 6-benzo-2- (bromomethyl) -1, 3-dioxepane (180.0 g, 0.74 mol) , t-BuOK (Sigma-Aldrich, 95.0%, 92.5 g, 0.96 mol) and 800 mL t-BuOH (Sigma-Aldrich, 98.0%) were added into a round-bottom flask and allowed to react under nitrogen at 80 ℃ for 24 h. After cooling to room temperature, the reaction mixture was poured into 2 L of diethyl ether. The insoluble material was removed by passing through Al
20
3. The diethyl ether was removed, and the crude liquid was distilled under reduced pressure to give a colorless liquid which solidified to white crystals (92.0 g) .
3. Preparation of PEG monocarboxylic acid polyester
Step 3.1 Synthesis of PEG-600 monocarboxylic acid
Platinum on charcoal (BASF Rome, 5.0 wt%Pt on C, water content of 59.7 wt%, 283 g, 29.2 mmol Pt) was suspended in a mixture of polyethylene glycol (Mn = 600) (1750 g, 2.92 mol) and water (4083 mL) , heated to 53 ℃ and stirred at 800 rpm. Oxygen was passed through the stirred mixture (20 mL/h) via a glass tube, equipped with a glass frit and the temperature was allowed to rise to 60 ℃. Oxygen dosage and temperature were maintained for the following 8 hours and 30 minutes and then oxygen dosage was stopped and the mixture was allowed to cool down to room temperature. Solids were separated from the liquid phase by filtration and the filter cake was washed with 500 mL of warm water. The washing water was mixed with the filtrate. Water was removed from the liquid mixture by distillation over a wiped film evaporator (overall height: 87.2 cm, diameter: 3.54 cm, wiped height: 43 cm, feed: 4.0 mL /min, 44 ℃, 18 mbar, 600 rpm) . The sump product (1812 g) from the wiped film evaporator contained 2.7 wt%water (determined by Karl-Fischer titration) and the conversion was determined by means of the acid number (91 mg KOH/g) .
Step 3.2 Synthesis of PEG-600 monocarboxylic acid polyester
PEG-600 monocarboxylic acid (100.0 g, 98%, with 2%water) was mixed with zinc octanoate (0.4 g) and heated for 48 hours under a vacuum of 100 mbar at 135 ℃.
II. Preparation and Characterization of Copolymers
Example 1: Preparation of copolymer of MTC and NVP (abbreviated as poly (MTC-NVP) )
m = 1 on average, and n = 3 on average Recrystallized AIBN (38 mg, 0.23 mmol) and MTC (1.5 g, 11.5 mmol) were dissolved in anhydrous dioxane (4.5 g) in a vial and degassed with dry nitrogen for 30 minutes before merging the vial into an oil bath at 80 ℃. Meanwhile, recrystallized AIBN (38 mg, 0.23 mmol) in dioxane (0.6 g) was dosed over 3 hours and NVP (3.8 g, 34.6 mmol) in dioxane (6.2 g) was dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 2: Preparation of copolymer of BMDO and NVP (abbreviated as poly (BMDO-NVP) )
m = 1 on average, and n = 3 on average Recrystallized AIBN (34 mg, 0.20 mmol) and BMDO (1.7 g, 10.4 mmol) were dissolved in anhydrous dioxane (2.5 g) a vial and degassed with dry nitrogen for 30 minutes before merging the vial into an oil bath at 80 ℃. Meanwhile, AIBN (34 mg, 0.20 mmol) in dioxane (0.6 g) was dosed over 3 hours and NVP (3.5 g, 31.2 mmol) in dioxane (1.5 g) was dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 3: Preparation of copolymer of MTC and NVI (abbreviated as poly (MTC-NVI) )
m = 1 on average, and n = 3 on average Recrystallized AIBN (38 mg, 0.23 mmol) and MTC (1.5 g, 11.5 mmol) were dissolved in anhydrous dioxane (4.5 g) a vial and degassed with dry nitrogen for 30 minutes before merging the vial into an oil bath at 80 ℃. Meanwhile, recrystallized AIBN (38 mg, 0.23 mmol) in dioxane (0.6 g) was dosed over 3 hours and N-vinyl imidazole (NVI, 3.3 g, 34.6 mmol) in dioxane (6.2 g) was dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 4: Preparation of copolymer of BMDO and NVI (abbreviated as poly (BMDO-NVI) )
m = 1 on average, and n = 3 on average Recrystallized AIBN (34 mg, 0.20 mmol) and BMDO (1.7 g, 10.4 mmol) were dissolved in anhydrous dioxane (2.5 g) a vial and degassed with dry nitrogen for 30 minutes before merging the vial into an oil bath at 80 ℃. Meanwhile, recrystallized AIBN (34 mg, 0.20 mmol) in dioxane (0.6 g) was dosed over 3 hours and NVI (3.3 g, 34.6 mmol) in dioxane (1.4 g) was dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 5: Preparation of poly (MTC-NVP) having PEG-carbonyl segments inserted into MTC ester units by transesterification (abbreviated as poly [ (MTC-NVP) -EO] )
In a vial, the poly (MTC-NVP) (2 g) as prepared in Example 1, the PEG monocarboxylic acid polyester (2 g) and zinc octanoate (0.08 g) were mixed. The mixture was purged by nitrogen for 30 min before heating up to 120 ℃. The transesterification was allowed to continue for 6 hours before cooling down to room temperature, yielding a viscous liquid. The obtained transesterification product contains a moiety of G inserted between -C (O) -and -O-in the ester bond -C (O) -O-in the MTC monomeric units, and the moiety of G is of formula
*-OCH
2CH
2 (O-CH
2CH
2)
11-CH
2C (O) -
**in which
*refers to the bond to -C (O) -and
**refers to the bond to -O-.
Example 6: Preparation of poly (MTC-NVP) having PEG-carbonyl segments inserted into MTC ester units by transesterification (abbreviated as poly [ (MTC-NVP) -EO] )
The preparation was carried out in the same manner as in Example 5, with the exception that 3 g of the PEG monocarboxylic acid polyester was used.
Example 7: Preparation of poly [ (BMDO-NVP) having PEG-carbonyl segments inserted into BMDO ester units by transesterification (abbreviated as poly [ (BMDO-NVP) -EO] )
In a vial, poly (BMDO-NVP) (2 g) as prepared in Example 2, the PEG monocarboxylic acid polyester (2 g) and zinc octanoate (0.08 g) were mixed. The mixture was purged by nitrogen for 30 min before heating up to 120 ℃. The transesterification was allowed to continue for 6 hours before cooling down to room temperature, yielding a viscous liquid. The obtained transesterification product contains a moiety of G inserted between -C (O) -and -O-in the ester bond -C (O) -O-in the BMDO monomeric units, and the moiety of G is of formula
*-OCH
2CH
2 (O-CH
2CH
2)
11-CH
2C (O) -
**in which
*refers to the bond to -C (O) -and
**refers to the bond to -O-.
Example 8: Preparation of poly [ (BMDO-NVP) having PEG-carbonyl segments inserted into BMDO ester units by transesterification (abbreviated as poly [ (BMDO-NVP) -EO] )
The preparation was carried out in the same manner as in Example 7, with the exception that 3 g of the PEG monocarboxylic acid polyester was used.
Example 9: Preparation of copolymer of poly (MTC-NVP) and poly (MTC-NVI) by transesterification (abbreviated as poly (MTC-NVP-NVI)
In a vial, poly (MTC-NVP) as prepared in Example 1 (4 g) , poly (MTC-NVI) as prepared in Example 3 (1 g) and zinc octanoate (0.1 g) were mixed. The mixture was purged by nitrogen for 30 min before heating up to 120 ℃. The transesterification was allowed to continue for 6 hours before cooling down to room temperature, yielding a viscous liquid as the resultant block copolymer. The obtained transesterification product contains blocks of NVP and blocks of NVI which are linked by ester linking units derived from MTC.
Example 10: Preparation of copolymer of poly (BMDO-NVP) and poly (BMDO-NVI) by transesterification (abbreviated as poly (BMDO-NVP-NVI)
In a vial, poly (BMDO-NVP) as prepared in Example 2 (4 g) , poly (BMDO-NVI) as prepared in Example 4 (1 g) and zinc octanoate (0.1 g) were mixed. The mixture was purged by nitrogen for 30 min before heating up to 120 ℃. The transesterification was allowed to continue for 6 hours before cooling down to room temperature, yielding a viscous liquid as the resultant block copolymer. The obtained transesterification product contains blocks of NVP and blocks of NVI which are linked by ester linking units derived from BMDO.
Example 11: Preparation of graft copolymer of PEG with poly (MTC-NVP) (abbreviated as poly [EO
1k-g- (MTC-r-NVP) ] )
MTC (1.5 g, 11.5 mmol) were dissolved in polyethylene glycol (Mn = 1,000, 5.64 g) in a vial and degassed with dry nitrogen for 30 minutes before merging the vial into an oil bath at 100 ℃. Meanwhile, tert-Butyl peroxy-2-ethylhexanoate (300 mg, 1.4 mmol) and NVP (3.8 g, 34.6 mmol) were dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 12: Preparation of graft copolymer of PEG with poly (MTC-NVP) (abbreviated as poly [EO
sk-g- (MTC-r-NVP) ] )
MTC (1.5 g, 11.5 mmol) were dissolved in polyethylene glycol (Mn = 5,000, 5.64 g) and degassed with dry nitrogen for 30 minutes before merging into an oil bath at 100 ℃. Meanwhile, tert-Butyl peroxy-2-ethylhexanoate (300 mg, 1.4 mmol) and NVP (3.8 g, 34.6 mmol) were dosed over 5 hours. The polymerization was allowed to continue for another hour before quenching by placing the vial into an ice bath. The polymerization solution was precipitated in diethyl ether. The precipitate was redissolved in dichloromethane and then precipitated in diethyl ether. The process of redissolution and precipitation was carried out three times to remove the residual reactants. The resultant polymer powder was then dried under vacuum overnight.
Example 13: Preparation of graft copolymer of PEG with poly (BMDO-NVP) (abbreviated as poly [EO
1k-g- (BMDO-r-NVP) ] )
The preparation was carried out in the same manner as in Example 11 with the exception that BMDO (1.86 g, 11.5mmol) was used instead of MTC.
Example 14: Preparation of a mixture of poly (BMDO-NVP) and PEG monocarboxylic acid polyester
A copolymer of BMDO and NVP (poly (BMDO-NVP) ) as prepared in Example 2 and a PEG monocarboxylic acid polyester at a weight ratio of 40∶ 60 were dissolved in water to provide the mixture.
Characterization
The parental copolymers (i.e., unmodified copolymers) before transesterification were characterized by Gel Permeation Chromatography (GPC) to obtain the molecular weight and distribution. The degree of polymerization (DP) ratio between the cyclic ketene acetal and the comonomer was calculated from
1H NMR. Copolymer sequence was characterized by backbone ester alkaline degradation experiment and subsequent mass spectrometry.
The polymers after transesterification were also characterized by GPC. The formation of multi-block copolymer structures, instead of polymer mixtures, was confirmed by the disappearance of the polymer peaks from the parental copolymers before transesterification and the appearance of the new polymer peak with unimodal-distribution and a broadened dispersity
Additionally, the multi-block copolymers were also characterized with Diffusion Ordered Spectroscopy (DOSY) , which relates to the chemical shifts of NMR resonances to their translational diffusion coefficient. The functional groups derived from the parental copolymers, including the ester bond from the cyclic ketene acetal and the heterocycles from NVP or NVI, exhibit similar diffusion coefficients, indicating that the blocks of the comonomers NVP or NVI are covalently bonded. The structural characterization results are summarized in Table 1.
Table 1
Ref. = Reference Example;
Inv. = Inventive Example;
Comp. = Comparative Example
The weight proportion of PEG-carbonyl segment moieties in the copolymers of Examples 5 and 7 as well as the graft copolymers of Examples 11 to 13 are all 50%. Therefore, the test comparison of the four Examples demonstrates the effect from polymer architectures, either multi-block linear copolymers or graft copolymers, on their application performance and biodegradability.
III. Performance Evaluation
III. 1 Anti-Adhesive Effect
The anti-adhesive properties of the copolymers as synthesized were evaluated using Quartz-Crystal Microbalance (QCM) characterization technique, which detects the kinetics of mass adsorption and allows to precisely monitor the coating process. The adsorbed copolymers according to the present invention in form of layer exhibit protein and cell-repellent properties, leading to a biologically inert surface on different kinds of fabrics.
The surface adsorption (SA) was determined by a Quartz-Crystal Microbalance with dissipation monitoring (QCM-D, a special embodiment of the QCM method) which measures the resonance frequency of a freely oscillating quartz crystal after excitation. The shift in resonance frequency scales inversely proportionally with mass changes at the quartz surface. The SA was calculated from the shift of the 7
th overtone of the resonance frequency according to the method of Sauerbrey. The Q-Sense Pro (Biolin Scientific Holding AB) operating system has a mass sensitivity of about 2 ng/cm
2. The QCM measurements were performed using standard flow-through methods with a flow rate of 20 μL/min at 23 ℃. A typical experiment comprised the following steps: Immersing the quartz plate in 1) a solution of 10 mmol/L of 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid (HEPES) in water with pH 7 (= “buffer” ) until a stable baseline was achieved; 2) in a solution of 0.1wt%polymer in buffer for 2 h; 3) in buffer for 2 h; 4) in a solution of 0.1wt%Skin milk powder in buffer for 0.5 h; 5) in buffer for 0.5 h. The mass change after polymer coating process and after Skin milk powder absorption amounts are summarized in Table 2.
Table 2
It can be seen, the copolymers according to the present invention exhibit excellent anti-adhesive property as indicated by the Iow protein absorption amounts. The anti-adhesive property of the copolymers according to the present invention is much better than that of corresponding graft copolymers derived from same comonomers, and comparable to that of the parental copolymers (i.e., unmodified copolymers before transesterification) , while have significantly improved biodegradability compared with the corresponding graft copolymers and parental copolymers as discussed hereinbelow. It was also found that the simple polymer mixture of Example 14 having the weight ratio between BMDO, NVP and PEG moieties same as that in the copolymer of Example 8 showed a similar polymer adsorption efficiency, yet worse anti-adhesive property.
III. 2 Dye-Transfer Inhibition Performance
Fabrics made of cotton were washed using a liquid detergent as shown in Table 3 containing a polymer additive (1 wt%) as shown in Table 4 at 40 ℃ in the presence of C.I. Direct Red 83.1 (1 wt%, based on the weight of the detergent formulation) . After the washing cycle as shown in Table 5, the fabrics were rinsed and dried. In order to evaluate the dye-transfer inhibition effect, the fabric whiteness before and after washing was determined by photometric measurement of the reflectance using an Elrepho 2000 photometer (Datacolor) at a wavelength of 650 nm. The test results for dye-transfer inhibiting effect are summarized in Table 4.
Table 3
lngredients | [%by weight] |
LAS (linear alkylbenzene sulfonate) | 6 |
AEO (C 12/C 14 fatty alCohol (7EO) ) | 24 |
Sodium Citrate | 0.5 |
Ethanol | 1.5 |
Propylene GlyCol | 5.0 |
Polymer Additive | 1.0 |
Deion ized Water | Add to 100 |
LAS: Disponil LDBS 5, Commercially available from BASF;
AEO: Lutensol A7N, Commercially available from BASF
Table 4
Polymer additive | Whiteness decrease |
Blank | 16.5 |
Sokalan HP K 30 * | 10.5 |
Example 1 (Ref. ) | 10.3 |
Example 3 (Ref. ) | 10.1 |
Example 5 (I nv. ) | 10.8 |
Example 6 (Inv. ) | 11.1 |
Example 9 (Inv. ) | 10.1 |
Example 11 (Comp. ) | 10.7 |
Example 12 (Comp. ) | 12.6 |
*alkoxylated polyethyleneimine (PEI) , commercially available from BASF
Table 5
Machine Type | Launder-o-meter, 120 rpm |
Washing Liquor/g | 200 |
Detergent/ [g/L] | 3 g/L |
Hard Water/ [mg CaCO 3/L] | 250 ppm |
Ca: Mg Ratio | 3∶ 2 |
Fabric Type | Polyester woven WFK 30A, Cotton knitted WFK 80A |
Fabric Size/cm*cm | 6*6 |
Washing Time/min | 30 |
Washing Temp. /℃ | 30 (1 st cycle) , 80 (2 nd cycle) |
Washing Cycle | 2 |
Washing Repeat | 1 |
Rinsing Condition | Tap water directly |
Dry Condition | Oyen 2 h, 50℃ |
Fabric Measurement | 2 nd cycle |
II. 3 Biodegradability
The biodegradability of the copolymers was evaluated by the assay of enzymatic degradability. Enzymes can catalyze hydrolysis of ester bonds into an alcohol and an acid. The acid produced by hydrolysis will lower the pH of the solution, which can be monitored by a pH-sensitive indicator. This method is based on a publication by Tokiwa (Hydrolysis of polyesters by lipases. Nature, 1977, 270, 76-78. ) . The pH shift is monitored by the absorbance change of bromothymol blue (pKs = 7.1) from 615 nm (blue) to 433 nm (yellow) . By measuring both wavelengths in the beginning and over the course of the experiment, small changes can be monitored. By evaluating the ratio of these values of absorbance (433 nm/615 nm) rather than measuring the absolute values, the contribution of scattered light which can arise from undissolved polymer and/or aggregation during the experiment can be reduced. All samples are measured as triplicates to account for pipetting errors. Autohydrolysis (spontaneous hydrolysis in water) of the tested polymers was also tested as control trials without the addition of enzymes. A 5 % (w/v) aqueous copolymer solution was prepared in a test tube. A 0.6 mg/mL cutinase solution was prepared by dissolving the enzyme in a solution consisting of 50%1x PBS buffer (100 mM sodium phosphate buffer) and 50%glycerol and then added to the test tube. 1 mg/mL bromothymol blue (BTB) solution was used as indicator. A 6000 μL of reaction solution was prepared by mixing 0 μL (control) or 240 μL of the cutinase solution, 600 μL of a PBS buffer (100 mM) , 1200 μL of the BTB solution, and balance of water.
The solution was shaken reciprocally at 30 ℃. The results are summarized in Table 6.
Table 6
1) AV= Average; 2) SD = Standard Deviation
Biodegradation in wastewater was also tested in triplicate using the OECD 301F manometric respirometry method. 30 mg/mL test substance was inoculated into wastewater taken from Mannheim Wastewater Treatment Plant and incubated in a closed flask at 25℃ for 28 days. The consumption of oxygen during this time is measured as the change in pressure inside the flask using an OxiTop C (WTW) . Evolved CO2 is absorbed using an NaOH solution. The amount of oxygen consumed by the microbial population during biodegradation of the test substance, after correction using a blank, is expressed as a percentage of the ThOD (Theoretical Oxygen Demand) . The percentage indicates the biodegradation extent. The test results are summarized in Table 7.
Table 7
Examples | 28 days (%) | 56 days (%) |
1 (Ref. ) | 8 | 10 |
2 (Ref. ) | 5 | 10 |
5 (Inv. ) | 60 | 65 |
6 (Inv. ) | 65 | 70 |
7 (Inv. ) | 60 | 60 |
8 (Inv. ) | 65 | 65 |
11 (Comp. ) | 35 | 40 |
12 (Comp. ) | 1 5 | 20 |
It can be seen that the copolymers according to the present invention have significantly improved biodegradability compared with the corresponding graft copolymers (Examples 11 and 12) and parental copolymers (Examples 1 and 2) .
II. 4 Compatibility with Biocide in a Liquid Laundry Formulation
Liquid laundry detergent formulations were prepared, which comprises 1%by weight of the copolymers according to the present invention as shown in Table 8, optionally 0.3 %of the biocide
HP 100 or 1%phenoxyethanol. The formulations were prepared by first preparing a premix containing surfactants, solvents, fatty acid, citric acid and NaOH, as shown in Table 8, and water up to 90%. This premix was prepared by adding all components to the appropriate amount of water and stirring at room temperature. Subsequently, the pH was set to pH=8.5 using NaOH. Then the final formulations were prepared by stirring at room temperature: 90%of this premix, the appropriate concentrations of the copolymer, optionally
HP 100 or 2-phenoxyethanol, and water up 100%. For the purpose of comparison, a standard liquid detergent formulation neither containing a copolymer of the invention nor a biocide was prepared. All amounts indicated in Table 8 are provided as active ingredients.
Materials:
AEO: C
12/C
14 fatty alcohol (7EO) (BASF Product)
AES: Alcohol Ethoxysulfate (BASF Product)
LAS: Linear alkylbenzene sulfonate (BASF Product)
Coco fatty acid: Edenor K12-18 (Emery Oleochemicals)
HP 100: commercial product containing 30%of the antimicrobial active 4, 4’-dichoro 2-hydroxydiphenylether (BASF Product)
Claims (24)
- A copolymer, which comprises- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and optionally interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-,- blocks derived from one or more ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-,provided that the ester linking units containing a moiety of -C (O) -O-are interrupted by the polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-when the blocks are derived from one ethylenically unsaturated comonomer.
- The copolymer according to claim 1, which comprises- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and interrupted by a polyoxyalkylene-carbonyl segment between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, and- blocks derived from one or more, preferaly one, ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
- The copolymer according to claim 1 or 2, wherein the polyoxyalkylene-carbonyl segment is represented by a general formula of*-O-R- [O-R] m- [O-R 1] n- [O-R 2] o-O-R 3-C (O) -** (I)whereinR, R 1 and R 2 are independently of one another, a linear or branched C 2-12-alkylene, provided that any two of R, R 1 and R 2 in adjacent blocks are different from each other,R 3 is a linear or branched C 1-11-alkylene,m is a number of 1 or higher,n and o are independently of one another, a number of 0 or higher,* represents the bond to the carbonyl “-C (O) -” of the moiety of -C (O) -O-in the interrupted ester linking units, and** represents the bond to the oxygen “-O-” of the moiety of -C (O) -O-in the interrupted ester linking units.
- The copolymer according to any of preceding claims, wherein the polyoxyalkylene-carbonyl segment is a polyoxyethylene-carbonyl segment of formula (I) in which R is ethylene, n and o are zero and R 3 is -CH 2-, or a polyoxypropylene-carbonyl segment of formula (I) in which R is 1, 2-propylene, n and o are zero and R 3 is 1, 1-ethylene.
- The copolymer according to any of preceding claims, wherein the polyoxyalkylene-carbonyl segment have a number average molecular weight (Mn) in the range of 400 to 1500, preferably 400 to 1200, more preferably 400 to 800.
- The copolymer according to claim 1, which comprises- ester linking units containing a moiety of -C (O) -O-, which have been derived from a cyclic ketene acetal via radical ring-opening polymerization and not interrupted between the carbonyl “-C (O) -” and the oxygen “-O-” of the moiety of -C (O) -O-, andblocks derived from two or more, preferaly two, ethylenically unsaturated comonomers, which are linked by the ester linking units containing a moiety of -C (O) -O-.
- The copolymer according to any of preceding claims, wherein the cyclic ketene acetal is selected from the group consisting of 2-methylene-1, 3-dioxepane of formula (III) , 5, 6-benzo-2-methylene-1, 3-dioxepane of formula (IV) , 2-methylene-1, 3, 6-trioxocane of formula (V) , 5, 6-dialkyl-2-methylene-1, 3-dioxepane of formula (VI) , 2-methylene-1, 3-dioxolane of formula (VII) , and 4, 5-dialkyl-2-methylene-1, 3-dioxolane of formula (VIIII)wherein R 4 and R 5 in formula (VI) and (VIII) are, independently of one another, a linear or branched alkyl, preferably C 1-12-alkyl group.
- The copolymer according to any of preceding claims, wherein the one or more ethylenically unsaturated comonomer are selected from the group consisting of (meth) acrylic acid, alkyl (meth) acrylates such as methyl (meth) acrylate and butyl (meth) acrylate, maleic acid, maleic acid anhydride, itaconic acid, itaconic anhydride, N-vinylpyrrolidinone, N-vinyl imidazole, vinyl esters such as vinyl acetate, preferably selected from the group consisting of N-vinylpyrrolidinone and N-vinyl imidazole.
- The copolymer according to any of preceding claims, wherein the blocks derived from one or more ethylenically unsaturated comonomers have an average number of repeating monomeric units in the range of 1 to 10, preferably 1 to 8, more preferably 1 to 5 per block.
- The copolymer according to any of preceding claims, wherein the cyclic ketene acetal and the one or more ethylenically unsaturated comonomers are polymerized at a molar ratio in the range of 1 ∶ 1 to 1 ∶ 10, preferably 1 ∶ 1 to 1 ∶ 8, more preferably 1 ∶ 1 to 1 ∶ 5, most preferably 2∶ 5 to 1∶ 5 during the preparation of the copolymer.
- A process for preparing a copolymer, preferably the copolymer according to any of preceding claims, which includes steps of(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester, or (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking unitswherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
- The process according to claim 11, which includes steps of(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and(b) subjecting the first unmodified copolymer to transesterification with (i) a polyalkylene oxide monocarboxylic acid polyester.
- The process according to claim 11 or 12, wherein the polyalkylene oxide monocarboxylic acid polyester is a polyester of polyethylene oxide monocarboxylic acid, a polyester of polypropylene oxide monocarboxylic acid, a polyester of polyoxybutylene monocarboxylic acid, a polyester of poly (ethylene oxide-propylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-propylene oxide-ethylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-butylene oxide) monocarboxylic acid, a polyester of poly (ethylene oxide-butylene oxide-ethylene oxide) monocarboxylic acid.
- The process according to claim 13, wherein the polyalkylene oxide monocarboxylic acid polyester is a polyester of polyethylene oxide monocarboxylic acid or a polyester of polypropylene oxide monocarboxylic acid, preferably polyethylene oxide monocarboxylic acid.
- The process according to claim 11, which includes steps of(a) providing a first unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units, and(b) subjecting the first unmodified copolymer to transesterification with (ii) a second unmodified copolymer comprising ester linking units derived from a cyclic ketene acetal via radical ring-opening polymerization and comprising blocks derived from an ethylenically unsaturated comonomer and linked by the ester linking units,wherein the first unmodified copolymer and the second unmodified copolymer differ from each other in the cyclic ketene acetal forming the ester linking units and/or in the ethylenically unsaturated comonomer forming the blocks, preferably in the ethylenically unsaturated comonomer forming the blocks.
- The process according to claim 15, wherein the first unmodified copolymer and the second unmodified copolymer comprise the same ester linking units derived from a cyclic ketene acetal.
- The process according to any of claims 11 to 16, wherein the cyclic ketene acetal is as defined in preceding claim 7.
- The process according to any of claims 11 to 17, wherein the one or more ethylenically unsaturated comonomer is as defined in claim 8.
- A cleansing composition or a fabric and home care composition, which comprises a copolymer according to any of claims 1 to 10, or a copolymer obtainable or obtained from the process according to any of claims 11 to 18, and at least one surfactant.
- The cleansing composition or the fabric and home care composition according to claim 19, which comprises 2-phenoxyethanol, preferably in an amount of 2 ppm to 5%, more preferably 0.1 to 2%by weight, based on the total weight of the composition.
- The cleansing composition or fabric and home care composition according to claim 19, which comprises 4, 4’-dichloro-2-hydroxydiphenylether, preferably in an amount of 0.001 to 3%, preferably 0.002 to 1%, more preferably 0.01 to 0.6%, based on the total weight of the composition.
- The cleansing composition or the fabric and home care composition according to any one of claims 19 to 21, which comprises at least one enzyme, preferably at least one enzyme selected from the group consisting of proteases, amylases, lipases, cellulases, hemicellulases, mannanases, xylanases, DNases, dispersins, pectinases, oxidoreductases, and cutinases.
- A method of preserving an aqueous detergent composition comprising a copolymer according to any of claims 1 to 10 or a copolymer obtainable or obtained from the process according to any of claims 11 to 18 against microbial contamination or growth, which includes adding 2-phenoxyethanol in the detergent composition.
- A method of laundering fabric or cleansing hard surfaces, which includes an antimicrobial treatment of a fabric or a hard surface with a detergent composition comprising a copolymer according to any of claims 1 to 10 or a copolymer obtainable or obtained from the process according to any of claims 11 to 18 and 4, 4’-dichloro-2-hydroxydiphenylether.
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024119440A1 true WO2024119440A1 (en) | 2024-06-13 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3047003B1 (en) | Use of modified polyaspartic acids in detergents | |
KR20160105790A (en) | Random copolymers as soil release agents in laundry processes | |
US20240132668A1 (en) | Amphiphilic alkoxylated polyalkylene imines or alkoxylated polyamines | |
US20240110009A1 (en) | New alkoxylated polyalkylene imines or alkoxylated polyamines | |
RU2673812C2 (en) | Method for producing polyaspartic acids | |
EP3046948B1 (en) | Modified polyaspartic acids, their preparation and their use as dispersion agent and scale inhibitors in washing, rinsing and cleaning compositions and in water treatment | |
KR20210006389A (en) | Dishwashing detergent formulation comprising graft polymers based on oligosaccharides and polysaccharides and polyaspartic acid as film inhibitory additives | |
WO2024119440A1 (en) | Biodegradable multi-block copolymers comprising linking units derived from cyclic ketene acetal | |
CA3226256A1 (en) | Detergent composition comprising detersive surfactant and graft polymer | |
EP3892707A1 (en) | Liquid detergent composition, kit and dosing system | |
WO2023017062A1 (en) | Biodegradable graft polymers | |
WO2023180212A1 (en) | A block copolymer, preparation process and composition thereof | |
WO2023017061A1 (en) | Biodegradable graft polymers for dye transfer inhibition | |
WO2023017064A1 (en) | Biodegradable graft polymers | |
WO2024017797A1 (en) | Biodegradable graft polymers useful for dye transfer inhibition | |
WO2023021105A1 (en) | Modified alkoxylated polyalkylene imines or modified alkoxylated polyamines | |
CN117795048A (en) | Biodegradable graft polymers for dye transfer inhibition | |
WO2023021101A1 (en) | Modified alkoxylated polyalkylene imines | |
CN117813330A (en) | Biodegradable graft polymers | |
WO2023117602A1 (en) | Water-soluble graft polymer, their preparation, uses, and compositions comprising such polymers | |
WO2023021103A1 (en) | Modified alkoxylated oligoalkylene imines and modified alkoxylated oligoamines | |
WO2023021104A1 (en) | Modified alkoxylated polyalkylene imines and modified alkoxylated polyamines obtainable by a process comprising the steps a) to d) | |
WO2024042005A1 (en) | Process for producing sulfatized esteramines | |
EP4134420A1 (en) | Detergent composition comprising detersive surfactant and biodegradable graft polymers | |
WO2023117494A1 (en) | Polypropylene imine polymers (ppi), their preparation, uses, and compositions comprising such ppi |